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In older adults, diabetes is a serious public health problem because of high prevalence as 
well as its devastating consequences such as functional disability and high mortality. Loss of 
muscle mass and strength, called sarcopenia, has been considered as a common pathway leading 
to loss of function and frailty in older adults. We investigated the impact of diabetes on skeletal 
muscle mass and strength in 3,075 older adults aged 70 to 79, enrolled in the Health, Aging and 
Body Composition Study. Diabetes was defined not only by self report or medication use, but 
also by fasting plasma glucose and the result of 75-g oral glucose challenge test. Muscle mass 
was measured by state of the art techniques such as dual-energy X-ray absorptiometry (DXA) 
and computed tomography (CT). Muscle strength was assessed quantitatively by isometric and 
isokinetic dynamometers. Muscle quality was defined as maximal muscle strength per unit 
muscle mass. In cross-sectional study, we found that muscle strength was significantly lower in 
men with diabetes and not higher in women with diabetes despite of having greater muscle mass 
than those without diabetes. Muscle quality was consistently lower in both men and women with 
diabetes than non-diabetic counterparts in both upper and lower extremities. We also found that 
longer duration (≥ 6 yrs) and poor glycemic control (A1c > 8.0 %) were associated with even 
lower muscle quality. In longitudinal study, older adults with diabetes showed about 50% greater 
declines in leg muscle strength compared with those without diabetes. Leg muscle quality also 
 iii 
declined more rapidly in older adults with diabetes. Skeletal muscle mass, estimated by DXA, 
declined more rapidly in older adults with diabetes. Interestingly, loss of muscle mass was more 
pronounced in undiagnosed diabetes. Thigh muscle area by CT declined two times faster in older 
women with either diagnosed or undiagnosed diabetes than non-diabetic women. The public 
health importance of these findings is that diabetes is clearly a risk factor for loss of muscle mass 
and strength in older adults. We need to develop a strategy to prevent rapid loss of muscle mass 
and strength in this high risk population. 
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1. INTRODUCTION 
 
1.1  SPECIFIC AIMS 
 
Sarcopenia, a loss of skeletal muscle mass, is commonly observed in older adults. [1-4] 
Loss of skeletal muscle strength is also one of typical changes with aging. [5-7] Previous studies 
have demonstrated that low muscle mass and decreased muscle strength is associated with 
devastating processes in elderly such as functional limitations, [8-10] physical disability, [11-14] 
falls, [15] loss of independence, [16] and mortality. [17-22] However, the risk factors or 
determinants for loss of muscle mass and strength in older adults are not fully understood. 
Advanced age, male sex, and black race are some of known factors associated with sarcopenia. 
[4, 23] Many chronic health conditions, such as cardiovascular disease, diabetes, osteoarthritis, 
and kidney failure, are potential risk factors of sarcopenia and need to be elucidated. 
Deterioration of glucose metabolism is another common characteristic related to aging 
process. [24-28] Healthy older adults have higher glucose levels during oral glucose tolerance 
tests, as well as delayed glucose disappearance during intravenous glucose tolerance tests, than 
do young healthy subjects. [29] Not only does the prevalence of diabetes mellitus increase with 
age, but also the incidence rate of new cases increases in people older than the age of 65 years. 
[30] Diabetes in older adults has been shown to be associated with two- to three fold increased 
risk of physical limitations and disability. [31-35] However, the impact of diabetes mellitus on 
the skeletal muscle mass and strength in older adults are largely unknown.  
The Health, Aging, and Body Composition (Health ABC) Study is a large on-going 
epidemiologic study of well-functioning community-dwelling black and white older men and 
1
women. The Health ABC Study was designed to investigate the relationship between changes in 
body composition and functional decline with aging. This cohort is ideally suited to study the 
cross-sectional association of diabetes with muscle mass and strength, as well as longitudinal 
impact of diabetes on the changes in muscle mass and strength. We hypothesize that older adults 
with diabetes will show lower skeletal muscle strength and/or lower muscle quality defined by 
maximal strength per unit muscle mass. In addition, we hypothesize that older adults with 
diabetes will show accelerated loss of skeletal muscle mass, strength, and muscle quality than 
non-diabetic older adults. 
This is a cross-sectional and longitudinal study to examine the impact of diabetes mellitus 
on the skeletal muscle quantity and quality in older adults to achieve the following scientific 
objectives: 
1. To assess whether older adults with diabetes have lower skeletal muscle strength 
and/or lower muscle quality. 
2. To determine the impact of diabetes on the longitudinal changes in skeletal muscle 
mass and strength, thus establish a temporal relationship between diabetes and muscle 
mass and strength. 
3. To investigate potential dose-response relationship between diabetes mellitus and 
changes in muscle mass and strength by examining the cumulative effects by duration 
of exposure (duration of diabetes) and by severity of exposure (glycosylated 
hemoglobin as an indicator of diabetes severity).  
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1.2  BACKGROUND AND SIGNIFICANCE 
 
1.2.1    Epidemiology of diabetes mellitus in older adults 
1.2.1.1    Prevalence 
 
The prevalence of diabetes mellitus is continuously increasing in the United States as 
well as in the world. [24-27] There are 14.7 millions of people with diagnosed diabetes in U.S. in 
year 2004. [30] This number has been doubled during the past 10 years. The major contribution 
to the rapidly increasing burden of diabetes is the aging population. In 1998, 12.7% of persons 
aged 70 and older had a diagnosis of diabetes. [27] The age specific prevalence of diabetes is the 
highest in adults aged 65 to 74, followed by age 75 and older, and age 45 to 64. There are also 
large numbers of older adults, almost 11% of the U.S. population aged 60 to 74, with 
undiagnosed diabetes. In the Health ABC Study, approximately one-third of all older people with 
diabetes remains undiagnosed. [28] If undiagnosed diabetes is combined with previously 
diagnosed diabetes, about one in five older adults aged 65 and older will have diabetes. Not only 
the prevalence, but also the incidence rate of diabetes increases in people older than the age of 65 
years. In 2004, the incidence of diagnosed diabetes was over five times higher among adults 
aged 65-79 years (14.9 per 1000 population) than adults less than 45 years of age (2.9 per 1000 
population). [30] From 1997 through 2004, the incidence of diagnosed diabetes increased in all 
the age groups examined. Incidence increased 45% among persons aged 18-44 years (from 2.0 to 
2.9 per 1000 population), increased 34% among persons aged 45-64 years (from 8.5 to 11.4 per 
1000 population), and increased 43% among persons aged 65-79 years (from 10.4 to 14.9 per 
1000 population). Furthermore, it is estimated that adults aged 65 and older will make up most of 
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the diabetic population in the next 25 years. Particularly, adults aged 75 and older will consist of 
one third of all diabetes population by year 2050. [27] 
 
1.2.1.2 Morbidity and mortality 
 
 
Older persons with diabetes have higher rates of premature death, functional disability, 
and coexisting illnesses such as hypertension, coronary heart disease, and stroke. [31-35] 
Mortality in adults with diabetes is about 2 times higher in men and 3 times higher in women 
than adults without diabetes. [36-37] The high mortality in adults with diabetes is mainly 
attributable to the increased risk of death from ischemic heart disease, cerebrovascular disease, 
and infectious diseases. Mortality ratio in adults with diabetes is about 1.8 to 3.3. [37] In older 
adults, diabetes is associated with a 2- to 3- fold increased risk of physical disability. [31-35] 
Physical disability is one of under-appreciated complications of diabetes, besides cognitive 
disorders, falls, fractures and other geriatric syndromes. [38] Among 5 million older adults with 
diabetes, 1.2 million or one quarter are unable to do major physical tasks such as walking one 
quarter of a mile, climbing 10 stairs, or doing housework. 2.5 million or one half have some 
difficulty doing these tasks. [31] Diabetes is also associated with subclinical functional limitation 
in community dwelling well functioning older adults in the Health ABC Study. [34] However, 
the mechanism for impaired physical function in diabetes has been poorly understood. Chronic 
conditions frequently combined with diabetes such as coronary heart disease, peripheral artery 
disease, visual impairment, and depression partially explained the association but still 40 % of 
excess risk for physical disability remained unexplained. [32] In 2002, a total cost of 132 billion 
4
dollars are attributable to diabetes including 92 billion dollars for direct medical costs and 40 
billion dollars of indirect costs related to disability, work loss, and premature mortality. [39] 
 
1.2.2 Skeletal muscle mass and strength in older adults 
 
            Adequate skeletal muscle mass and strength is a crucial component to maintain physical 
function, mobility and vitality in old age. [8-14] Sarcopenia is a term used to describe the age-
associated loss of skeletal muscle mass, although the definition is still unclear. [1-3] 
Baumgartner, et al. [1] defined sarcopenia as appendicular skeletal muscle mass/height-squared 
(aLM/ht2 in kg/m2) being less than two standard deviations below the mean of a young reference 
group. Prevalence of sarcopenia increased from 13-24% in persons under 70 years of age to 
above 50% in persons over 80 years of age in New Mexico Study. [1] However, Baumgartner’s 
method (aLM/ ht2) was less sensitive to detect sarcopenia in woman and overweight or obese 
individuals. Newman, et al. [3] used appendicular lean mass adjusted for height and body fat 
mass by residuals and it was more strongly associated with lower extremity functional 
limitations (odds ratio=1.9, 95% CI=1.4-2.5) in the Health ABC Study.  
  In general, skeletal muscle strength declines with increasing age beginning at age 40 to 
50. [40-54] Muscle strength of older adults aged 70 and older is about 60 % of the strength of 
young adults. In other words, people lose about 40% of their muscle strength with aging. Even 
greater decline of strength more than 50% has been observed for people in their nineties. 
Typically, the rate of strength decline was reported to be 12 to 15% per decade in cross-sectional 
studies (Table 1). [23, 40-50] However, it is likely that previous cross-sectional studies 
underestimated the true age-related decreases in muscle strength because stronger persons may 
5
have had a better chance to survive to old age and to be examined in baseline cross-sectional 
comparisons (survival effect bias). Indeed, longitudinal studies have reported greater declines of 
muscle strength around 2-3% per year (Table 2). [55-58] Previous studies also reported greater 
declines of muscle strength in lower extremities than upper extremities. (Table 1 and 2) 
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Table 1. Selected studies of age related changes in skeletal muscle strength (cross-sectional studies) 
Author, 
Year 
[Reference] 
Age Sex  N Results Comments 
Larsson L, 
1979 [40] 
11 - 70 
yrs 
M 114 Strength peaked at age 33-34 yr, remained 
stable to the 40-49 yr, and then decreased 
by 26 – 38 %.  
Descriptive study, Eight 
age groups 
Muscle biopsy showed a 
lower proportion of type 
II fibers with age. 
Murray MP, 
1980 [41] 
20 - 86 
yrs 
M 72 Strength of the men in the older age groups 
was significantly less than that of the 
youngest group (55% of young men) 
Comparisons between 
three age groups 
Murray MP, 
1985 [42] 
20 - 86 
yrs 
F 72 Strength of the oldest group ranged from 56 
to 78% of that in the youngest group, 
depending on knee joint position. 
Comparisons between 
three age groups 
Young A, 
1985 [43] 
70s vs 
20s 
M 24 The mean isometric strength of the 
quadriceps muscles of 12 healthy men in 
their seventies was 39% less than that of 12 
healthy men in their twenties. 
Comparison between two 
groups 
Young A, 
1984 [44] 
70s vs 
20s 
F 50 The older women were 35% weaker than 
the young women and their quadriceps 
cross-sectional area was 33% . 
Comparison between two 
groups 
Vandervoor
t AA, 1990  
[45] 
70s vs 
20s 
F 52 Elderly women had significantly lower peak 
and average torque values in all 
comparisons with the young female group 
(25 to 54% lower) 
Comparison between two 
groups 
Overend TJ,  
1992 [46] 
70s vs 
20s 
M 25 Compared to the young men, elderly men 
had significantly smaller quadriceps 
muscles and were weaker (22-32%) in knee 
flexion and knee extension. 
Comparison between two 
groups 
Poulin MJ,  
1992 [47] 
60s vs 
20s 
M  24 Compared to young men, older men had 
lower concentric peak torque values for 
knee (32%) extensors. 
Comparison between two 
groups 
Lindle RS,  
1997 [48] 
20-93 
yrs 
M 
F 
346 
308 
Both men and women exhibited age-related 
declines in knee extensor strength starting 
in the fourth decade at a rate of ~8-10% per 
decade (a 33% declines in men and 35% 
declines in women). 
Regression analysis 
Muscle quality (MQ: 
strength/thigh FFM) was 
defined. MQ declined 
with aging. 
Lynch NA,  
1999 [49] 
 
19 – 
93 yrs 
M 
F 
364 
339 
Both genders exhibited an age-related 
decline in leg muscle quality by ~ 40%, the 
rate of decline was similar for men and 
women. 
Regression analysis 
 
Metter EJ, 
1999 [50, 
51] 
20 – 
90 yrs 
M 
F 
353 
322 
Muscle strength of older adults (aged 80s) 
was about 60 % of 20 year olds in both men 
and women. Muscle quality declined with 
age. 
Regression analysis 
 
Newman 
AB, 
2003 [23] 
70 - 79 M 
F 
3075 Decline in leg strength: -1.9 ~ -2.1%/yr 
Decline in arm strength: -1.1 ~ -1.5%/yr 
Whites and blacks 
Muscle quality declined: -
1%/yr 
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Table 2. Selected studies of age related changes in skeletal muscle strength (Longitudinal studies) 
Author, Year 
[Reference] 
Age Sex  N Results Comments 
Aniansson A,  
1992 [55] 
 
Mean: 69 
yr 
M 9 Muscle strength for knee extension 
declined by 25-35% over 11-yr period. 
(2-3%/yr) 
Histology showed a reduction of type 
IIb fibers with increase in fiber area.  
Only men 
11 yr follow-up 
Final age: 80.4 yrs old 
Rantanen T,  
1998 [56] 
45 - 68 M 3,741 Annualized strength decline was ~ 1%. 
Steeper decline (>1.5%/yr) was 
associated with old age, greater weight 
loss, and chronic conditions.  
Grip strength only 
27 yr follow-up period 
Japanese-American men 
Frontera WR,  
2000 [57] 
65.4 ± 
4.2 
M 12 Loss of 24% of initial knee extensor 
strength (a rate of decline: -1.98 ± 1.22 
% / yr) 
Muscle strength at baseline and the 
changes in muscle CSA were 
independent predictors of strength 
levels at Yr 12. 
Histology showed a reduction of type I 
fibers and decreased capillary density. 
Only men, 
12 yr longitudinal study 
* Larger reductions of 
strength in lower 
extremities compared 
with the upper 
extremities 
Hughes VA, 
2001 [58] 
46 - 78 
yrs 
M 
F 
52 
78 
The rate of decline in knee extensor 
strength: 1.4 %/yr 
The change in leg strength was directly 
related to the change in muscle mass in 
both men and women. 
 
9.7 yrs follow up,  
* longitudinal rates of 
decline was ~ 60% 
greater than estimates 
from a cross-sectional 
analysis in the same 
population. 
 
            Age-related loss of skeletal muscle mass and strength (sarcopenia) contribute to the 
development of functional limitations and disability in older adults. Many studies have been 
showing the relationship of muscle mass and physical limitations and/or muscle strength and 
disability. [8-9, 11-14] Although both muscle mass and muscle strength are related to physical 
limitations, muscle strength is more powerful predictor of incident physical limitations. [14] 
Skeletal muscle weakness has been consistently reported as an independent risk factor for high 
mortality in older adults. [17-21] Again, low skeletal muscle strength, but not muscle mass, is 
associated with high mortality in community-dwelling older adults enrolled in the Health ABC 
Study. [22] As a matter of facts, muscle mass and muscle strength are closely inter-correlated. It 
has been thought that muscle strength is mainly determined by the quantity of muscle mass 
8
because muscle strength is highly correlated with muscle mass (r=0.5~0.7). [5-7] However, 
muscle strength seems to be influenced by the changes in muscle quality as well. For instance, 
changes in muscle composition such as reduction of the proportion in type IIb fibers with 
increase in type I fibers, [59] infiltration of fat cells, [60] and increase in connective tissue 
components seem to have an important role in relation to functional limitations and disability. 
Neurological mechanisms like a reduction in alpha motor unit number, slowing of axonal 
conduction velocity, segmental demyelination also contribute declines in skeletal muscle 
strength. [61] More recently, it is suggested that alterations in the endocrine milieu and increase 
in proinflammatory cytokines have important roles in the process of sarcopenia. [62-64] 
 
1.2.3 Diabetes mellitus and skeletal muscle strength (Systematic review) 
 
           There are only a few studies examining skeletal muscle strength in diabetes. The previous 
literature in this topic is reviewed systematically because the association of diabetes and muscle 
strength is the main topic of the current study.  
 
1.2.3.1 Methods for finding literatures 
 
 
OVID was used to perform a literature search on the database MEDLINE (1966-2005). 
The initial search by using key words “muscle strength” and “diabetes” revealed 79 articles. The 
search was limited to human studies, published in the English language, and with an available 
electronic abstract. There were 71 articles which remained after this restriction. The abstracts of 
71 articles were reviewed to select relevant articles. The following papers were excluded: animal 
studies, laboratory experimental studies, or review papers. The articles had to meet the following 
9
criteria to be included: 1) human subject research, 2) the data had to contain quantitative 
measurements of skeletal muscle strength. After reviewing 71 abstracts, four studies met all the 
selection criteria and were included in this review. Two of them studied skeletal muscle strength 
in type 1 diabetes [65, 66] and the other two studied muscle strength in type 2 diabetes [67, 68]. 
To summarize, four case control studies were included in this review. Manual screening of the 
bibliography in the selected article has been performed as well. This literature search was 
performed on October 15th, 2005. 
 
1.2.3.2   Study design and selection of subjects 
 
In all studies combined, skeletal muscle strength data was available for 144 subjects with 
diabetes mellitus (100 with type 1 diabetes and 44 with type 2 diabetes) and 152 subjects without 
diabetes. The study design and characteristics of subjects included in this review are summarized 
in Table 3. Four studies were case control studies of persons with either type 1 or type 2 diabetes 
and healthy control subjects. [65-68] In the case control studies, the cases were selected from 
outpatient clinics of participating hospitals. Particularly, subjects with type 1 diabetes were 
chosen from those who had duration of diabetes greater than 20 years. For subjects with type 2 
diabetes, the mean duration of diabetes was about 9 to 11 years. All four case control studies 
enrolled only persons with known and treated diabetes in a hospital setting from a single center. 
In two of the case control studies, the control subjects were recruited among hospital employees, 
blood donors, friends and relatives, which may contain selection bias. One study did not report 
the recruitment method and one study recruited the control subjects by advertising in the local 
press. The control subjects were matched for age, sex, height and weight [65-66, 68] or at least 
by weight. [67] The study by Halvitsiotis, et al. had no information about the gender of subjects 
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and included lean control subjects with totally different body size (BMI: 25.0 ± 0.5 compared to 
29.7 ± 0.9 in type 2 diabetic subjects, p=0.001). [67] 
Table 3. Study design and characteristics of subjects included in the studies of skeletal muscle 
strength in diabetes mellitus, 1996-2005. 
Author, 
publication 
yr, reference 
Study 
design 
Type of 
diabetes 
Cases Controls 
Andersen H. 
et al., 1996 
[65] 
Case 
Control 
Type 1  56 cases: 19 women and 39 men 
Selected from outpatient clinic 
Diabetes duration > 20 yrs 
No severe cardiac or lung disease 
Aged 31 - 64 yrs 
56 healthy controls matched for 
age, sex, height, and weight  
Recruited among hospital 
employees, blood donors, friends, 
and relatives 
Andersen H, 
1998 [66] 
Case 
Control 
Type 1  44 cases: 16 women and 28 men 
Selected from outpatient clinic 
Diabetes duration > 20 yrs 
Age: 46 ± 9 yrs 
44 healthy controls matched for 
age, sex, height, weight and 
weekly physical activity 
Recruited among hospital 
employees, blood donors, friends, 
and relatives 
Halvatsiotis 
P. et al, 2002  
[67] 
Case 
Control 
Type 2  
 
8 cases  
No information about sex 
Mean duration of diabetes: 8.5 yrs 
(3-19 yrs),  Age: 56 ± 2 yrs 
8 weight-matched controls  
Additional 8 lean control subjects 
No information about recruitment 
Andersen H. 
et al, 2004  
[68] 
Case 
Control 
Type 2  
 
36 cases: 13 women and 23 men 
Mean duration of diabetes 11 yrs 
(5-26 yrs) 
Aged 44 - 69 yrs 
36 healthy controls matched for 
age, sex, height and weight 
Recruited by advertising in the 
local press 
 
1.2.3.3   Assessments of muscle strength  
 
 The methods for the quantitative assessments of skeletal muscle strength of the four studies 
are presented in Table 4. Three out of four studies measured maximal isokinetic strength (peak 
torque) using isokinetic dynamometer. [65-66, 68] One study measured peak isometric strength. 
[67]. Three studies used a LidoActive Multi joint II (Loredan Biomedical, West Sacramento, 
CA) while two studies used a Kin-Com dynamometer (Chattanooga, TN). Two studies measured 
muscle fatigability by using either endurance index or fatigue rate. [66-67] Three studies 
examined muscle strength in both upper and lower extremities, while two studies examined only 
in lower extremities. However, all four studies measured muscle strength at knee extension, 
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which has been considered as the most physiologically important and reliable site for strength 
measurements. [23]  
 
Table 4. Summary of measurements and results of skeletal muscle strength in diabetes mellitus, 
1996-2005. 
Author, 
publication yr, 
reference 
Measurements  Main findings 
Andersen H. 
et al., 1996 
[65] 
Isokinetic muscle testing: maximal isokinetic 
strength (peak torque) of the ankle dorsal and 
plantar flexion, knee extension and flexion, 
wrist extension and flexion 
21% reduction in ankle dorsal and plantar 
flexor strength, 16% reduction of knee 
extensor strength 
10-11% non-significant reduction of wrist 
muscle strength.  Muscle weakness is related 
to the presence and severity of neuropathy. 
Andersen H, 
1998 [66] 
Subjects were instructed to perform 30 
maximal isokinetic movements. 
Endurance index was defined by the work of 
the last five repetitions as a percentage of the 
work of the first five repetitions. 
Patients with type 1 diabetes had reduced 
strength of all muscle groups by 14-24%, but 
increased muscular endurance. 
Halvatsiotis P. 
et al, 2002  
[67] 
Peak voluntary isometric torque of knee 
extensor was measured at a knee angle of 60o 
of flexion. 
Fatigue rate was calculated from the line of 
best fit through the data. 
Muscle strength was unaffected by diabetes 
and glycemic status (before and after glycemic 
control). 
Type 2 diabetic subjects showed increased 
tendency for muscle fatigability. 
Andersen H. 
et al, 2004  
[68] 
Maximal isokinetic strength (peak torque) of 
extension and flexion at the ankle, knee, 
elbow, and wrist was assessed by an isokinetic 
dynamometer. 
17 and 14 % reduction of strength of ankle 
flexors and extensors, 7% (NS: exact p-value 
not given) and 14% (p<0.05) reductions of 
strength of knee extensors and flexors, Muscle 
strength was preserved at the elbow and wrist.  
Muscle weakness is related to the presence 
and severity of peripheral neuropathy 
 
1.2.3.4 Muscle strength in subjects with diabetes 
   
Subjects with diabetes, whether type 1 or type 2, showed reduced skeletal muscle strength 
compared with non-diabetic controls in all studies except the study by Halvatsiotis, et al. (Table 
4). [65-68] In fact, even in Halvatsiotis’ study, [67] peak isokinetic torque of knee extension was 
lower in subjects with type 2 diabetes compared to weight-matched control subjects (mean ± SE: 
67 ± 9 vs 102 ± 18 Nm), but similar to lean control subjects (79 ± 18 Nm). However, there was 
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no statistically significant difference between groups (p=0.345). [67] It is noticed that their study 
had small sample size (8 cases and 8 weight-matched controls), which seem to be responsible for 
the insignificant finding due to low power.  
     Table 5 summarizes maximal isokinetic strength in subjects with either type 1 or type2 
diabetes and controls. The studies in type 1 diabetes consistently show that diabetic patients have 
reduced strength of muscle groups in the lower extremities. [64-65] However, the difference of 
muscle strength in the upper extremities was not statistically significant. [65] The findings are 
quite similar in type 2 diabetes. Andersen et al. reported reduced muscle strength in the lower 
extremities in subjects with type 2 diabetes. [68] Again, there was no difference in muscle 
strength of the upper extremities. However, among the four studies reviewed, there was no 
measurement of skeletal muscle mass. No study reported muscle quality after controlling for the 
differences in muscle mass between subjects with and without diabetes. Two studies examined 
muscular endurance. [66, 67] Andersen et al. reported increased muscular endurance in subjects 
with long standing type 1 diabetes. [66] In contrast, Halvatsiotis et al. showed increased 
tendency for muscle fatigability in subjects with type 2 diabetes. [67] 
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Table 5. Results of maximal isokinetic strength in diabetic and control subjects, 1996-2005. 
Author, study 
yr, reference 
N Muscles 
examined 
Diabetic subjects 
(Nm) 
Control subjects 
(Nm) 
P value 
Andersen H. 
et al., 1996 
[65] 
56 Knee extensor 
Knee flexor 
Ankle dorsal 
Ankle plantar 
Wrist extensor 
Wrist flexor 
150.8 ± 38.5 
82.4 ± 20.2 
24.3 ± 6.8 
87.8 ± 23.2 
8.5 ± 2.4 
15.1 ± 3.6 
178.6 ± 52.8 
99.6 ± 31.0 
30.7 ± 7.5 
111.0 ± 28.7 
9.5 ± 3.2 
16.8 ± 5.4 
<0.0001 
<0.01 
<0.0001 
<0.01 
NS† 
NS 
Andersen H, 
1998 [66] 
44 Knee extensor 
Knee flexor 
Ankle extensor 
Ankle flexor 
117.2 ± 33.0 
67.3 ± 21.4 
19.4 ± 4.9 
55.6 ± 14.2 
136.1 ± 39.2 
80.1 ± 26.1 
22.9 ± 5.1 
73.0 ± 18.1 
<0.02 
<0.02 
<0.005 
<0.005 
Halvatsiotis P. 
et al, 2002  
[67] 
8 Knee extensor 67 ± 9  102 ± 18 (weight 
matched control) 
79 ± 18 (lean control) 
0.345* 
Andersen H. 
et al, 2004  
[68]** 
36 Knee extensor 
Knee flexor 
Ankle extensor 
Ankle flexor 
Wrist  
Elbow 
Reduced by 7 % in diabetics than controls 
Reduced by 14 % in diabetics than controls 
Reduced by 14 % in diabetics than controls 
Reduced by 17 % in diabetics than controls 
No difference 
No difference 
0.26 
<0.05 
<0.03 
<0.02 
NS 
NS 
Data are mean ± SD, except Halvatsiotis’ (SE). †NS: Not significant (exact p-value not given in the original article)  
*ANOVA test between three groups.  ** Actual strength data are not available.  
 
 
 
1.2.3.5   Factors associated with muscle strength in diabetes    
 
In both type 1 and type 2 diabetes, muscle strength is related to the presence and 
severity of peripheral neuropathy, but not with retinopathy or nephropathy. [65-66, 68] The 
correlations between the neuropathy rank-sum score (NRSS) and muscle strength were moderate 
to high (r = -0.41 ~ -0.66, p < 0.05). NRSS was defined as a summation of the rank scores of a 
neuropathy symptom score, a neurological disability score, and rank scores of 
electrophysiological measures. [68] In Halvatsiotis’ study, muscle strength was unaffected by 
glycemic status before and after strict glycemic control. [67] However this observation was 
based on a limited number of samples (8 subjects with type 2 diabetes and 8 control subjects). 
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1.2.3.6   Limitations of Previous Studies 
  
           The studies of skeletal muscle function in subjects with either type 1 or type 2 diabetes 
showed generally lower muscle strength in diabetic subjects. Only one study by Halvatsiotis, et 
al. failed to demonstrate a statistically significant difference. [67] It should be considered that 
lean control subjects in their study were totally different compared with subjects with type 2 
diabetes in terms of body size (BMI: 25.0 ± 0.5 versus 29.7 ± 0.9, p=0.001). Halvatsiotis, et al. 
compared diabetic subjects with lean and weight-matched control groups by analysis of variance 
test. [67] But, they had to compare only weight matched controls with those with type 2 diabetes 
by independent t-tests because it has been well known that skeletal muscle strength depends 
largely on the muscle mass which again closely correlates with body size. [51] Comparison of 
muscle strength between two groups of subjects with different body size may be confounded by 
differences in muscle mass. Furthermore, the small sample size (n=24 including 8 cases, 8 lean 
controls and 8 weight-matched controls) of the study might have limited power to detect true 
differences.  
     In both type 1 and type 2 diabetes, lower skeletal muscle strength was observed in lower 
extremities (ankle and knee), but not in upper extremities (wrist and elbow). In fact, relative 
preservation of upper extremity strength is a common phenomenon observed in many cross-
sectional and longitudinal studies of aging adults. [49, 57-58] It is possible that the neuropathic 
process of diabetes may have an influence predominantly on the lower extremities. It is 
consistent with the findings of Andersen et al. [65, 68] They showed that muscle strength is 
related to the presence and severity of peripheral neuropathy in type 1 as well as type 2 diabetes. 
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It is also well known that diabetic neuropathy predominantly involves the lower extremities. [69-
71] 
       In the previous case-control studies, researchers tried to match controls for age, sex, height 
and weight or at least by weight. However, it does not mean that the muscle mass of diabetic 
subjects and controls are the same. It is well known that subjects with type 2 diabetes are more 
obese not only in terms of general adiposity as evidence by BMI, but also regional adiposity or 
central obesity. So, it is still possible that body composition may differ between cases and 
matched controls. Unfortunately, previous studies did not measure body composition with state 
of the art technology, [72] and therefore could not adjust for the muscle mass. The measure of 
muscle quality is a more reasonable indicator of contractile function of skeletal muscle than 
crude muscle strength, which is largely dependent on the quantity of muscle mass. This concept 
might be important particularly for the comparison of skeletal muscle function between subjects 
with different body size like those with and without diabetes.  
     Only a few studies have tried to identify factors associated with muscle strength and quality 
in diabetes. [65, 68]  In both type 1 and type 2 diabetes, muscle strength is associated with the 
presence and severity of peripheral neuropathy, but not with retinopathy or nephropathy. 
However, it is hard to generalize the findings because subjects with type 1 diabetes in their study 
had a long duration of diabetes more than 20 years. [65, 66] Further research is needed to 
investigate whether this association is present in persons with shorter duration of diabetes as 
well.  
     In summary, skeletal muscle strength is lower in subjects with diabetes regardless of type 1 
or type 2 diabetes. Lower extremities are predominantly affected by diabetes with relative 
preservation of upper extremity strength. The major problem with previous studies on skeletal 
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muscle strength and diabetes is limited external validity because they selected severe cases with 
long duration of diabetes in the hospital setting. Population based cross-sectional and prospective 
cohort studies are needed to examine the association of diabetes with skeletal muscle strength 
and to investigate whether subjects with diabetes experience longitudinal declines in muscle 
strength and muscle quality.  
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2.1   ABSTRACT 
 
      Adequate skeletal muscle strength is essential for physical functioning and low muscle 
strength is a predictor of physical limitations. Older adults with diabetes have a 2- to 3-fold 
increased risk of physical disability. However, muscle strength has never been investigated with 
regard to diabetes in a population-based study. We evaluated grip and knee extensor strength and 
muscle mass in 485 older adults with diabetes and 2,133 without diabetes in the Health, Aging 
and Body Composition Study. Older adults with diabetes had greater arm and leg muscle mass 
than those without diabetes as they were bigger in body size. Despite this, muscle strength was 
lower in men with diabetes and not higher in women with diabetes than corresponding 
counterparts. Muscle quality, defined as muscle strength per unit regional muscle mass, was 
significantly lower in men and women with diabetes than those without diabetes in both upper 
and lower extremities. Furthermore, longer duration of diabetes (≥ 6 yrs) and poor glycemic 
control (HbA1c > 8.0 %) were associated with even poorer muscle quality. In conclusion, 
diabetes is associated with lower skeletal muscle strength and quality. These characteristics may 
contribute to the development of physical disability in older adults with diabetes. 
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2.2    INTRODUCTION 
 
        In the United States, people 65 years and older will make up most of the diabetic population 
in the next 25 years. Furthermore, the proportion of the diabetic population 75 years or older is 
projected to exceed 30 % by 2050. [1, 2] In older adults, diabetes has been associated with a 2- to 
3- fold increased risk of developing physical disability. [3-6] Moreover, we have reported the 
association of diabetes with subclinical functional limitation in the Health, Aging and Body 
Composition (Health ABC) Study. [7] However, the mechanism for impaired physical function 
in diabetes has been poorly understood. Chronic conditions frequently combined with diabetes 
such as coronary heart disease, peripheral artery disease, visual impairment, and depression 
partially explained the association but still 40 % of excess risk for physical disability remained 
unexplained. [4, 6]  
Low muscle strength, but not muscle mass, is associated with poor physical function in 
older men and women. [8, 9] Muscle strength measured in midlife or old age is highly predictive 
of functional limitations and disability up to 25 years later. [10-12] However, the effects of 
diabetes on muscle strength and quality have never been investigated in a population-based 
study. Because most individuals with diabetes are obese and have bigger muscle mass, as well as 
increased total body fat mass, direct comparison of their muscle strength with those without 
diabetes may be misleading. With the advent of body composition analysis, we are now able to 
precisely measure regional muscle mass and quantitatively assess in vivo skeletal muscle quality 
defined as maximal voluntary contractile force or torque per unit regional muscle mass of the 
specific body compartment. [13] 
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In the present study, we evaluated hand grip and knee extensor strength and muscle quality in 
community dwelling older adults with and without diabetes in the Health ABC study. To 
evaluate the cumulative effects of metabolic derangements of diabetes on skeletal muscle 
function, subjects with diabetes were further categorized by the duration of diabetes and the level 
of glycemic control.     
 
2.3   METHODS 
 
2.3.1  Participants 
 
 The Health ABC Study included 3,075 well functioning older adults, of whom 51.6% were 
women and 41.6% African-Americans. Whites were recruited from a random sample of 
Medicare beneficiaries residing in ZIP codes from the metropolitan areas surrounding Pittsburgh, 
Pennsylvania and Memphis, Tennessee. African-Americans were recruited from all age-eligibles 
in these geographic areas. Eligibility criteria included: aged 70 to 79 in the recruitment period 
from March 1997 to July 1998; self-report of no difficulty walking one-quarter of a mile or 
climbing 10 steps without resting; no difficulty performing basic activities of daily living; no 
reported use of a cane, walker, crutches or other special equipment to ambulate; no history of 
active treatment for cancer in the prior 3 years; and no plan to move out of the area in the next 3 
years. All individuals gave informed consent for participation in the study and the consent forms 
and study protocols were approved by the institutional review boards at each field center. Among 
3,075 participants, 29 (0.9%) who had missing fasting plasma glucose concentrations were 
excluded and 6 subjects with the onset of diabetes before age 25 were considered as having type 
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1 diabetes and excluded from the analyses. Among the remaining 3,040 participants, 389 
subjects (12.8 %) were excluded from the knee strength test due to uncontrolled hypertension, 
history of stroke or aneurysm in the brain, bilateral knee joint replacement, presence of severe 
bilateral knee pain, or refused by the participant. Another 33 (1.1%) who had missed body 
composition assessment by dual energy X-ray absorptiometry (DXA) were also excluded. 
Finally, 2,618 participants (85.1 % of original cohort), including 485 (18.5 %) with type 2 
diabetes and 2,133 without diabetes, who had completed muscle strength test and DXA 
measurements of body composition, were included in the analyses.  
 
 
2.3.2 Assessment of diabetes  
 
Participants were considered as having type 2 diabetes if they had either (i) a report of 
having been diagnosed as diabetes with the onset after age 25 and/or (ii) current use of oral 
hypoglycemic medications or insulin, or (iii) having a fasting plasma glucose concentration 
equal or greater than 7.0 mmol/l. [14] We used information on reported age at diagnosis to define 
diabetes duration; for participants with newly diagnosed diabetes, the duration of diabetes were 
considered as zero.  The duration of diabetes ranged from 0 to 45 years with the median of 6.0 
years. Plasma glucose was measured using an automated glucose oxidase reaction (Vitros 950 
analyzer, Johnson and Johnson, Rochester, NY) and a glycosylated hemoglobin (HbA1c) was 
measured in all participants by enzymatic method (Bio-Rad, Hercules, CA).  
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2.3.3 Assessment of body composition 
 
Body weight and height were measured in a hospital gown and without shoes on a 
calibrated balance beam scale and stadiometer, respectively, and a body mass index (BMI) in 
kg/m2 was calculated.  Lean mass of the upper and lower extremities as well as the total body 
were assessed using DXA (Hologic QDR 4500, software version 8.21). Bone mineral content 
was subtracted from the total and regional lean mass to define total non-bone lean mass, which 
represents primarily skeletal muscle in the extremities. [15] Total body fat mass was measured 
and percent body fat was calculated. 
 
2.3.4 Assessment of muscle strength  
 
Muscle strength was measured using an isokinetic dynamometer (Kin-Com 
dynamometer, 125 AP, Chattanooga, TN) for knee extension and isometric dynamometer 
(Jaymar, JLW Instruments, Chicago, IL) for grip strength. For knee extension, maximal 
voluntary concentric isokinetic torque was assessed in Newton-meters (Nm) at angular velocity 
of 60o/s. At least three, but no more than six, maximal efforts were allowed to produce three 
overlying curves and the mean maximal torque was recorded and used for the analysis. The right 
leg was used unless contraindicated by pain or history of joint replacement. Isometric grip 
strength was assessed for each hand. Participants with severe hand pain or recent surgery were 
excluded. The vast majority (96 %) who had leg strength testing also had grip strength testing. 
For these analyses, we used the maximum of the force from two trials for the right upper 
extremity.  A measure of muscle quality (leg specific torque; Nm/kg, arm specific force; kg/kg) 
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was created by taking the ratio of strength to the entire corresponding leg or arm muscle mass in 
kg measured by DXA. [13] 
 
2.3.5 Other covariates 
 
 Sociodemographic characteristics included age, gender, race, and education. Combined 
chronic health conditions were summarized as comorbidity score which was defined as number 
of the following ten prevalent conditions: coronary heart disease, congestive heart failure, 
cerebrovascular disease, peripheral artery disease, knee osteoarthritis, hypertension, depression, 
pulmonary disease, cancer, and osteoporosis. Each condition was identified by self report and 
confirmed by treatment and medication use. Self-reported poor eyesight was considered as 
impaired vision. Renal insufficiency was defined by serum creatinine greater than 1.5 mg/dl in 
men, and 1.2 mg/dl in women. [16] Health-related behaviors which included current smoking, 
alcohol drinking, and physical activity, were also considered as potential confounders. Level of 
total physical activity (kcal/week) was determined using a standardized questionnaire designed 
specifically for the Health ABC Study. [17]  
 
2.3.6 Statistical analysis  
 
 Differences in means and proportions of baseline characteristics and body composition by 
diabetes status were tested using Student’s t-tests and chi-square tests. Differences in muscle 
strength and quality between subjects with and without diabetes were also assessed by 
independent t-tests. There was a significant interaction between diabetes status and gender in 
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relation to muscle strength (p = 0.003). Therefore, all of the following analyses were stratified by 
gender. Adjustments for potential confounders were performed using multiple regression models 
by cumulative addition of sociodemographic factors and physical activity (model 1), plus body 
mass index (model 2), plus smoking, alcohol drinking, combined chronic health conditions, and 
diabetes related complications (model 3). To test the effects of duration and severity of diabetes 
on muscle strength and quality, analysis of variance (ANOVA) tests for trend were used. When 
overall differences were significant with ANOVA, post hoc comparisons were performed with 
Bonferroni adjustment. A p-value of <0.05 was accepted as statistically significant. All the 
analyses were performed using SPSS software (version 12.0.0, SPSS Inc., Chicago, IL).  
 
2.4   RESULTS 
 
  Among 485 older adults with type 2 diabetes, 389 (80.2%) had previously known diabetes 
while 96 (19.8%) were newly diagnosed by fasting plasma glucose criteria. Most diabetic 
subjects were treated with oral hypoglycemic medications (216, 44.5%) or insulin injections (99, 
20.4%), while one third (170, 33.7%), including newly diagnosed subjects, were taking no 
diabetic medications. Participants with diabetes were more likely to be black, and less educated. 
Older men and women with diabetes had higher weight, BMI, total body fat, and total body lean 
mass than nondiabetic counterparts. As expected, diabetes-related complications, such as 
impaired vision and renal insufficiency were twice more prevalent in those with diabetes. Older 
adults with diabetes also had higher comorbidity scores compared to nondiabetic subjects. Those 
with diabetes reported less alcohol use and less physical activity (Table 6).   
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  Table 7 presents arm and leg muscle strength, corresponding regional muscle mass, and 
muscle quality by diabetes status. In men, those with diabetes showed significantly lower muscle 
strength in both upper and lower extremity (p < 0.05, each) although their arm and leg regional 
muscle mass were significantly greater than those without diabetes (p < 0.001, each). In women, 
absolute arm and leg muscle strength were not significantly different in those with diabetes in 
spite of greater arm and leg regional muscle mass than those without diabetes. Muscle quality 
was consistently lower in both upper and lower extremities in both men and women with 
diabetes compared to nondiabetic counterparts (all; p < 0.001, Table 7). There was no significant 
difference in the relationship of diabetes to muscle quality in blacks compared to whites (p for 
interaction = 0.31 and 0.70 in men, 0.17 and 0.76 in women for leg and arm muscle quality 
respectively). 
     Lower muscle quality in men and women with diabetes was slightly attenuated after 
adjustment for race, age, clinic site, and physical activity (Table 8, model 1). However, 
adjustment for BMI attenuated the difference in muscle quality by 17 to 37 % in men and by 49 
to 69 % in women (Table 8, model 2). Adjustment for total fat mass instead of body mass index 
gave the same result (data not shown). Further adjustments for smoking, alcohol drinking, 
combined chronic diseases, impaired vision, and renal insufficiency virtually eliminate the effect 
of diabetes on muscle quality in women. But, in men, lower muscle quality associated with 
diabetes remained even in the fully adjusted model (Table 8, model 3).     
Muscle quality was associated with diabetes duration in both upper and lower extremities 
in both men and women. Those with the longer duration of diabetes (≥ 6 years) showed the 
lowest muscle quality (Figure 1). There was also a linear trend between the level of glycemic 
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control and muscle quality. Diabetic subjects with poor glycemic control (HbA1c > 8.0 %) had 
the lowest muscle quality regardless of sex and muscle groups examined (Figure 2). 
 
 
2.5    DISCUSSION 
 
    In our study, older adults with type 2 diabetes had a greater muscle mass in their arm and leg 
than those without diabetes. But despite this larger muscle mass, those with diabetes were either 
weaker (men) or not stronger (women) than those without diabetes. This finding was somewhat 
surprising because the quantity of muscle mass had been known as a primary determinant of 
muscle strength. [13, 18-20] We have clearly demonstrated that muscle quality was consistently 
lower in older adults with type 2 diabetes, regardless of sex and muscle groups examined (arm or 
leg). This is a novel finding possibly explaining a pathophysiological mechanism for increased 
risk of functional limitations and disability in older adults with type 2 diabetes, because low 
muscle strength or poor muscular function is predictive of physical disability. [8-12] Our finding 
is consistent with the study in patients with type 1 diabetes. [21] We have also found that lower 
muscle quality in older adults with diabetes was largely attenuated by adjustment for BMI, 
indicating obesity might have important role in this association. We have previously reported 
that skeletal muscle attenuation coefficient determined by computerized tomography was lower 
with increasing BMI and it was independently associated with muscle strength and quality. [22] 
Low muscle attenuation was also found in older adults with impaired glucose tolerance or type 2 
diabetes. [23] Reduced muscle attenuation values have been associated with reduced oxidative 
enzyme activity [24] and lower maximal aerobic capacity. [25] It is possible that alterations of 
muscle composition with increased fat infiltration into the skeletal muscle as evidenced by low 
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muscle attenuation in type 2 diabetes, which is also associated with combined obesity, may result 
in poor muscle quality. Further research will be needed to determine whether diabetes itself or 
the higher levels of body fat in the diabetes is a direct cause of poor muscle quality in a 
prospective study. 
   There had been no report on skeletal muscle strength or function in type 2 diabetes until 
Andersen et al. reported muscle weakness at the ankle and knee in a case-control study. [26] 
They showed a 7 to 17 % lower muscle strength at the ankle and knee in patients with type 2 
diabetes compared to controls. Although control subjects were matched for sex, age, weight, 
height, and physical activity, it was impossible to evaluate whether muscle weakness in subjects 
with type 2 diabetes was due to reduced muscle mass or poor muscle quality because muscle 
mass was not assessed in their study. In the present study, we measured arm and leg regional 
muscle mass separately by DXA. The concurrent measures of muscle mass and strength allowed 
us to evaluate in vivo muscle quality, which was defined as muscle strength per unit muscle mass 
in kg. This definition has been consistently used to assess muscle function in human subjects. [13, 
27-28] The specific force of arm and specific torque of leg represent the maximal contractile 
capacity of each appendicular skeletal muscle group adjusted for the quantity of muscle mass. 
Therefore, these measures of muscle quality are more reasonable indicator of contractile function 
of skeletal muscle than crude muscle strength, which is largely dependent on the quantity of 
muscle mass. This concept might be important particularly for the comparison of skeletal muscle 
function between subjects with different body size like those with and without diabetes.  
   The discrepancy between men and women in terms of differences in absolute muscle strength 
can be explained by the magnitude of differences in muscle mass between those with and 
without diabetes. Older men with diabetes had only slightly (4~5 %) higher appendicular muscle 
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mass than those without diabetes (Table 7). This small difference in muscle mass may not be 
enough to overcome poor muscle quality of diabetes, resulting in lower muscle strength in men 
with diabetes. But, women with diabetes had moderately (12~14 %) higher appendicular muscle 
mass than those without diabetes, which may be enough to compensate poor muscle quality and 
result in absolute muscle strength comparable to the non-diabetic women. However, despite of 
having similar muscle strength, older women with diabetes showed poor physical function in our 
previous report using the same cohort [7], suggesting their strength might be insufficient to carry 
their heavy weight.  
Another important finding of this study is a linear relationship showing both longer duration 
of diabetes and poor glycemic control are associated with much poorer muscle quality (Figure 1 
and 2). These findings are consistent with our previous observation that poor glycemic control in 
diabetic individuals explained the association with subclinical functional limitation. [7] A 
metabolic consequence of uncontrolled hyperglycemia is catabolism which, depending on the 
severity, is accompanied by muscle protein breakdown and inadequate energy utilization, 
potentially resulting in poor muscle function. Diabetes with poor glycemic control is also 
associated with increased systemic inflammatory cytokines, such as TNF-α and IL-6, which 
have detrimental effects on muscle function. [29-32]  
   Neuropathic processes involving motor neurons might be another possible underlying 
mechanism for the poor muscle function in diabetes. In the mouse model, after 4 weeks of 
diabetes, the relative loss of torque via nerve stimulation (~43 %) was greater than the force loss 
in the directly stimulated muscle (~24 %), indicating a functional neural deficit. [33] Although it 
is unclear in humans, a greater and selective atrophy of type IIb fibers have been observed in 
diabetic animal muscles [34-36], which may contribute to strength loss. In humans, the presence 
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and severity of diabetic neuropathy has been shown to be associated with decreased muscle 
strength in both type 1 and type 2 diabetes. [26, 37] Electrophysiologic studies suggest that loss 
of muscle strength in diabetic patients is due to incomplete reinnervation following axonal loss. 
[38] 
    The present study is the first epidemiologic study to assess skeletal muscle function in 
subjects with and without type 2 diabetes in apparently healthy, community dwelling older 
adults. The population includes white and black older men and women with type 2 diabetes in 
various clinical stages. We found a significantly lower muscle quality in older adults with 
diabetes though the difference is relatively small in magnitude. For the clinical implications, we 
have to consider that subjects with diabetes in this study were all well functioning without 
physical disability. The inclusion of asymptomatic subjects as diabetes group by fasting plasma 
glucose cut-point attenuated the difference in muscle quality (data not shown). In other words, 
older adults with diabetes seen in clinical setting might have even poorer muscle quality. It has 
been well established that lower muscle strength is an important contributor to disability. [10-12] 
However, the clinical significance of poor muscle function in diabetes for the development of 
disability can only be answered by a prospective study.  
This study has several limitations. First of all, this is a cross-sectional study showing only 
an association between type 2 diabetes and poor muscle function. It does not necessarily mean 
that type 2 diabetes in older adults result in poor muscle strength and quality. It is also possible 
that lower muscle quality is a causative factor related to the development of type 2 diabetes in 
older adults. However, even lower muscle quality in diabetic subjects with longer duration and 
poor glycemic control may suggest that poor muscle quality is likely a consequence rather than a 
cause of diabetes in older adults (Figure 1 and 2). Second, we have no data on diabetic 
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neuropathy at baseline, which may have important mediating role in muscle weakness. Despite 
these limitations, this study might have important public health implications as older adults with 
diabetes are at increased risk of developing physical disability and potential preventive strategies 
are available including resistive-training exercise program to improve skeletal muscle function in 
subjects with diabetes. [39]   
        In conclusion, type 2 diabetes is associated with lower skeletal muscle strength and quality 
in community dwelling older adults. These characteristics may contribute to development of 
physical disability in older adults with diabetes. Prospective studies are needed to investigate 
whether type 2 diabetes in older adults is associated with longitudinal declines in muscle strength 
and examine the relationship to the loss of muscle mass and muscle quality.  
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Table 6. Characteristics of the study population by diabetes status, according to gender    
                       Men                       Women  
 No diabetes 
(n, 1,004) 
Diabetes 
(n, 273) 
p No diabetes 
(n, 1,129) 
Diabetes 
(n, 212) 
P 
 
       
Age (years) 73.7 ± 2.9 73.8 ± 2.9 0.47 73.5 ± 2.8 73.2 ± 2.8 0.19 
Black (%) 32.2 45.4 <0.01 40.3 68.9 <0.01 
Education < 12 yrs (%) 24.5 32.0 0.01 19.8 37.1 <0.01 
Height (cm) 173.3 ± 6.5 173.5 ± 6.1 0.63 159.6 ± 6.2 159.6 ± 5.6 0.93 
Weight (kg) 80.3 ± 12.6 85.3 ± 13.8 <0.01 69.2 ± 14.1 76.9 ± 14.1 <0.01 
BMI (kg/m2) 26.7 ± 3.8 28.3 ± 4.0 <0.01 27.1 ± 5.2 30.2 ± 5.4 <0.01 
Total body fat (kg)  22.8 ± 6.9 24.9 ± 7.4 <0.01 27.9 ± 9.0 31.5 ± 9.2 <0.01 
Total body lean (kg)  54.9 ± 7.0 57.5 ± 7.4 <0.01 39.5 ± 5.8 43.4± 5.8 <0.01 
Fasting glucose (mmol/l) 5.3 ± 0.5 8.5 ± 2.9 <0.01 5.1 ± 0.5 8.4 ± 3.1 <0.01 
HbA1C (%) 6.0 ± 0.5 7.8 ± 1.5 <0.01 6.0 ± 0.5 8.0 ± 1.6 <0.01 
Impaired vision  (%) 18.7 28.3 <0.01 17.6 27.5 <0.01 
Renal insufficiency  (%) 7.5 15.9 <0.01 8.0 14.4 <0.01 
Comorbidity score * 1.25 ± 1.12 1.55 ± 1.18 <0.01 1.38 ± 1.14 1.78 ± 1.27 <0.01 
Smoking (current, %) 10.7 9.5 0.59 9.5 9.9 0.85 
Alcohol drinking (%) 60.6 46.2 <0.01 47.4 22.6 <0.01 
Physical activity 
(kcal/week) 
5,397 4,761 0.07 4,808 4,092 <0.01 
Data are means ± SD or proportion (%), except physical activity (median).  
*Comorbidity score: number of combined chronic diseases including coronary heart disease, congestive heart 
failure, cerebrovascular disease, peripheral artery disease, knee osteoarthritis, hypertension, depression, pulmonary 
disease, cancer, and osteoporosis. 
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Table 7. Comparison of arm and leg muscle strength, regional muscle mass, and muscle quality by 
diabetes status, stratified by gender 
                       Men                       Women  
 No diabetes 
(n, 1,004) 
Diabetes 
(n, 273) 
p No diabetes 
(n, 1,129) 
Diabetes 
(n, 212) 
p 
 
       
Leg strength (Nm) 133.0 ± 32.4 128.5 ± 34.6 0.046 81.1 ± 22.0 83.8 ± 21.4 0.096 
Leg muscle mass (kg) 8.7 ± 1.3 9.1 ± 1.4 <0.001 6.3 ± 1.2 7.0 ± 1.2 <0.001 
Leg muscle quality 
(Nm/kg) 
 
15.3 ± 3.2 14.2 ± 3.3 <0.001 13.0 ± 3.1 12.1 ± 3.2 <0.001 
Hand grip strength (kg) 40.0 ± 8.9 38.7 ± 8.8 0.037 24.3 ± 6.4 25.1 ± 5.9 0.098 
Arm muscle mass (kg) 3.4 ± 0.6 3.6 ± 0.6 <0.001 2.1 ± 0.4 2.3 ± 0.4  <0.001 
Arm muscle quality 
(kg/kg)  
11.7 ± 2.4 10.8 ± 2.3 <0.001 12.0 ± 2.9 11.0 ± 2.9  <0.001 
Data are means ± SD. 
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Table 8. Multiple regression models showing the effect of diabetes on arm and leg muscle quality, 
stratified by gender 
 Men  Women  
 β for 
diabetes 
S.E. p β for 
diabetes 
S.E. p 
Arm muscle quality (kg/kg)      
   Unadjusted -0.89 0.16 <0.001 -1.05 0.22 <0.001 
   Model 1 -0.84 0.16 <0.001 -0.85 0.22 <0.001 
   Model 2 -0.53 0.16 0.001 -0.43 0.21 0.043 
   Model 3 -0.50 0.16 0.002 -0.34 0.22 0.111 
Leg muscle quality (Nm/kg)      
   Unadjusted -1.10 0.22 <0.001 -0.87 0.24 <0.001 
   Model 1 -1.01 0.22 <0.001 -0.61 0.24 0.011 
   Model 2 -0.84 0.22 <0.001 -0.19 0.23 0.404 
   Model 3 -0.80 0.22 <0.001 -0.15 0.24 0.524 
Adjustments of covariates were performed using multiple regression analyses by cumulatively adding the following 
covariates into the model 
Model 1: race, age, clinic site, and physical activity 
Model 2: model 1 + body mass index 
Model 3: model 2 + smoking, drinking, comorbidity score, impaired vision, and renal insufficiency  
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Figure 1. Muscle quality in older adults with diabetes by duration. 
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Figure 2. Muscle quality in older adults with diabetes by HbA1c. 
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3. ARTICLE TWO: ACCERELATED LOSS OF SKELETAL MUSCLE STRENGTH IN 
OLDER ADULTS WITH TYPE 2 DIABETES: THE HEALTH, AGING AND BODY 
COMPOSITION STUDY 
 
 
3.1   ABSTRACT 
 
      Maintenance of skeletal muscle strength is essential for physical functioning and decreased 
muscle strength is a predictor of mobility limitations. Older adults with diabetes have a two- to 
threefold increased risk of physical disability. It is also reported that diabetes in older adults is 
associated with low muscle strength. However, it is unknown whether low muscle strength is a 
precedence or consequence of diabetes because longitudinal change of muscle function in 
diabetes has yet to be investigated. We examined leg and arm muscle mass and strength at 
baseline and 3 years later in 1,840 older adults in the Health, Aging and Body Composition 
Study. Both diabetic and non-diabetic older adults lost significant amount of muscle mass and 
strength in three years. Older adults with type 2 diabetes showed about 50% more rapid decline 
in the leg muscle strength compared with older adults without diabetes (p=0.001). Leg muscle 
quality, expressed as a maximal strength per unit muscle mass (Nm/kg), also declined more 
rapidly in older adults with type 2 diabetes (p<0.05). Changes in arm muscle strength and quality 
were not different between those with and without diabetes. Rapid declines in leg muscle 
strength and quality were attenuated but remained significant after controlling for demographics, 
body composition, combined chronic diseases, and inflammatory cytokines. In conclusion, older 
adults with type 2 diabetes showed accelerated loss of lower extremity muscle strength, which 
may be responsible for increased risk of mobility limitations. 
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3.2   INTRODUCTION 
 
        In industrialized countries, the major increase in the number of people with diabetes is 
attributed to the aging of the population. [1-2] The current burden of diabetes is already greatest 
in the population ≥ 65 years of age in the United States. Furthermore, the greatest increases in 
prevalence are expected among the elderly and eventually older adults ≥ 65 years old will make 
up 70 % of diabetic population in the next 25 years. [2] In older adults, diabetes is associated 
with a two- to threefold increased risk of developing physical disability. [3-7] Several factors 
have been identified as contributors to diabetes-related disability including obesity [3-4], 
coronary heart disease [3-4, 6], stroke [3], arthritis [3-4], depression [6], and visual impairments 
[3-4]. But still a large portion of diabetes-physical disability relationship is not explained by 
above factors. Alterations in muscular function in diabetes can be a potential pathway not yet 
fully explored.  
Muscle weakness in diabetes has been considered as a rare manifestation associated with 
severe diabetic neuropathy. However, recent studies using quantitative assessments of muscular 
function showed that skeletal muscle strength, especially in lower extremity, is lower in adults 
with diabetes than non-diabetic controls. [8-10] In the Health ABC Study, we have shown that 
older adults with type 2 diabetes have lower skeletal muscle strength and quality, defined as a 
maximal strength per unit muscle mass. [10] But, the previous studies have limitations of cross-
sectional observation and it is unclear whether low muscle strength in diabetes is a consequence 
of diabetes or just a coincidence. 
In the present study, we reexamined knee extensor and hand grip strength and body 
composition three years after baseline examination in the Health ABC Study to investigate 
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longitudinal changes in skeletal muscle strength and quality in relation to baseline diabetes 
status. We hypothesized that older adults with type 2 diabetes would show a greater declines in 
skeletal muscle function than older adults without diabetes. 
 
3.3   METHODS 
 
3.3.1   Participants 
 
The Health ABC Study included well-functioning community-dwelling older adults aged 70 
to 79 years, of whom 51.6% were women and 41.6% were black. Whites were recruited from a 
random sample of Medicare beneficiaries residing in ZIP codes from the metropolitan areas 
surrounding Pittsburgh, Pennsylvania and Memphis, Tennessee. Blacks were recruited from all 
age-eligible residents in these geographic areas. Eligibility criteria included: age 70 to 79 years 
old in the recruitment period from March 1997 to July 1998; self-report of no difficulty walking 
one-quarter of a mile or climbing 10 steps without resting; no difficulty performing basic 
activities of daily living; no reported use of a cane, walker, crutches or other special equipment 
to ambulate; no history of active treatment for cancer in the prior 3 years; and no plan to move 
out of the area in the next 3 years.  
Of the 3,075 participants, we excluded those with missing data on fasting plasma glucose (n 
= 29), those with diabetes onset before age 25 (n = 6), and those who had missing data on body 
composition (n =33). We also excluded 389 subjects (12.8%) from the knee strength test due to 
uncontrolled hypertension, history of stroke or aneurysm in the brain, bilateral knee joint 
replacement, presence of severe bilateral knee pain, or refusal by the participant. Of the 2,618 
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participants with complete baseline data, 1,840 (70.3 %) were reexamined for skeletal muscle 
strength and body composition at three years after baseline assessment. The reasons for not 
having 3-year follow-up data were death (n = 146), no clinic visit due to disability and/or 
institutionalization (n = 302; home examination, 245; proxy interview, 57), missed contact (n = 
77), withdrawal of the participants (n =11), unable to perform knee strength test (n = 191), and 
missing data on body composition (n = 51). All participants provided informed consent before 
participating in the study. The consent forms and study protocols were approved by the 
institutional review boards at each field center. 
 
 
3.3.2 Assessment of diabetes   
  
Participants were considered as having type 2 diabetes if they had either (i) a report of 
having been diagnosed as diabetes with the onset after age 25 and/or (ii) current use of oral 
hypoglycemic medications or insulin, or (iii) having a fasting plasma glucose concentration 
equal or greater than 7.0 mmol/l at baseline. We used information on reported age at diagnosis to 
define diabetes duration; for participants with newly diagnosed diabetes, the duration of diabetes 
were considered as 0. The duration of diabetes was ranged 0 to 45 years from time of diagnosis. 
The average duration was 9.7 ±10.9 years with the median of 5 years. Plasma glucose was 
measured using an automated glucose oxidase reaction (Vitros 950 analyzer, Johnson and 
Johnson, Rochester, NY) and a glycosylated hemoglobin (HbA1c) was measured by enzymatic 
method (Bio-Rad, Hercules, CA).  
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3.3.3 Assessment of body composition 
 
Body weight and height were measured in a hospital gown and without shoes on a 
calibrated balance beam scale and stadiometer, respectively, and a body mass index (BMI) in 
kg/m2 was calculated.  Lean mass of the upper and lower extremities as well as the total body 
were assessed using dual energy x-ray absorptiometry (DXA, Hologic QDR 4500, software 
version 8.21). Bone mineral content was subtracted from the total and regional lean mass to 
define total non-bone lean mass, which represents primarily skeletal muscle in the extremities.  
Total body fat mass was also measured and percent body fat was calculated.  
 
3.3.4 Assessment of muscle strength  
  
Strength was measured using an isokinetic dynamometer (Kin-Com dynamometer, 125 AP, 
Chattanooga, TN) for knee extension and isometric dynamometer (Jaymar, JLW Instruments, 
Chicago, IL) for grip strength. For knee extension, maximal voluntary concentric isokinetic 
torque was assessed in Newton-meters (Nm) at angular velocity of 60o/s. At least three, but no 
more than six, maximal efforts were allowed to produce three overlying curves and the mean 
maximal torque was recorded and used for the analysis. The right leg was used unless 
contraindicated by pain or history of joint replacement. For the validation of knee strength 
assessments, we performed a reliability study in 63 participants. The inter-examiner coefficient 
of variation (CV) was 4.85 % with no significant differences between examiners. The intra-
participant CV was 10.68 % and the CV for combined effect of examiner and participant was 
11.73%.  
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Isometric grip strength was assessed for each hand. Participants with severe hand pain or 
recent surgery were excluded. The vast majority (96 %) who had leg strength testing also had 
grip strength testing. For these analyses, we used the maximum of the force from two trials for 
the right upper extremity. A measure of muscle quality (leg specific torque; Nm/kg, arm specific 
force; kg/kg) was created by taking the ratio of strength to the entire corresponding leg or arm 
muscle mass in kg measured by DXA. Changes in muscle strength and quality were calculated as 
year 3 value minus baseline value, hence negative value means loss of muscle strength or quality.  
 
3.3.5    Other covariates 
 
 Sociodemographic characteristics included age, gender, race, and education. Combined 
chronic diseases such as coronary heart disease, congestive heart failure, stroke, peripheral artery 
disease, knee osteoarthritis, depression, and cancer were identified by self report and confirmed 
by treatment and medication use. Self-reported poor eyesight was considered as impaired vision. 
Renal insufficiency was defined by serum creatinine greater than 1.5 mg/dl in men, and 1.2 
mg/dl in women. [10] Ankle-arm index (AAI) was calculated and subclinical peripheral artery 
disease was defined by AAI < 0.9. Health-related behaviors included current smoking, alcohol 
drinking, and level of total physical activity (kcal/week) determined by using a standardized 
questionnaire designed specifically for the Health ABC Study. [11]  
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3.3.6   Statistical analysis  
 
Baseline characteristics of the cohort are presented separately for those with and without 
diabetes. Chi-square tests were calculated for categorical variables and a t-test was used for 
continuous variables to test for any statistical differences between the two groups. Longitudinal 
changes of muscle strength and quality were calculated in both absolute terms (year 4 value 
minus initial value) and relative terms (percent change from baseline). Differences between 
participants with and without diabetes were assessed by general linear models controlling for sex, 
race, age, clinic site, and baseline values when using absolute changes (model 1). Additional 
adjustments were made for body mass index, baseline muscle mass, and changes in muscle mass 
or weight change in case of muscle quality because it is already adjusted for muscle mass (model 
2), plus combined chronic diseases, and diabetes related complications (model 3), and health 
related behaviors such as smoking, alcohol drinking, and physical activity (model 4). There was 
no indication of interaction effect (p<0.10) of sex or race with diabetes on the changes in muscle 
strength or muscle quality. A p-value of <0.05 was accepted as statistically significant. All the 
analyses were performed using SPSS software (version 12.0.0, SPSS Inc., Chicago, IL).  
 
3.4 RESULTS 
 
Among the 1,840 participants with complete assessments of baseline and year 3 follow-up 
strength test and body composition, 305 (16.6%) had type 2 diabetes at baseline. Older adults 
with type 2 diabetes were more likely to be men, black and have a lower level of education 
(Table 9). Those with diabetes had greater body weight, body mass index, total fat mass as well 
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as higher total lean mass than non-diabetic counterparts. As expected, combined chronic 
conditions such as coronary heart disease, peripheral artery disease, impaired vision and renal 
insufficiency were more prevalent in those with type 2 diabetes. Interleukin-6 and tumor necrosis 
factor-α levels were significantly higher in older adults with diabetes (Table 9). 
Both diabetic and non-diabetic older adults lost significant amount of initial muscle 
strength in three years. However, older adults with type 2 diabetes lost their knee extensor 
strength more rapidly than those without diabetes (p=0.001, Table 10). Older adults with type 2 
diabetes also lost greater amount of leg lean mass than those without diabetes (p<0.05). 
Furthermore, muscle quality (maximal strength per unit muscle mass, Nm/kg) declined more 
rapidly in older adults with type 2 diabetes (p<0.05). When expressed in relative changes, older 
adults with type 2 diabetes showed about 50 % more rapid loss of knee extensor strength (-9.0 % 
vs. -13.5 %, p=0.002) and muscle quality (-6.2 % vs. -10.0 %, p=0.01) than those without 
diabetes (Figure 3). However, the changes in hand grip strength and arm muscle quality were not 
different between those with and without diabetes although older adults with diabetes lost greater 
amount of arm muscle mass (Table 10, Figure 3). 
 Table 11 presents the changes in knee extensor strength and muscle quality controlling for 
potential confounders. A greater decline of knee extensor strength in participants with type 2 
diabetes was not changed by adjustments for sex, race, age, clinic site, body mass index, baseline 
strength, and changes in leg muscle mass (model 2). This association of diabetes and loss of knee 
extensor strength was slightly attenuated by additional adjustments for combined chronic 
diseases and inflammatory cytokines (Table 11, model 3 and 4).  
A greater decline of leg muscle quality in older adults with type 2 diabetes were evident after 
adjustments for demographics, body mass index, baseline muscle quality, and changes in leg lean 
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mass (p=0.001, model 2). Further adjustments for combined chronic diseases and inflammatory 
cytokines attenuated only minimally the association of diabetes and declines of muscle quality. 
The greater declines of muscle strength and quality in older adults with type 2 diabetes were 
remained significant throughout the models (Table 11). Further adjustments for smoking, alcohol 
drinking, and level of physical activity did not change the results (data not shown). 
  
3.5     DISCUSSION 
 
In this study, older adults with type 2 diabetes lost 13.5 % of their knee extensor strength 
while those without diabetes lost 9.0 % of initial strength in three years. About 50 % more rapid 
decline in the knee extensor strength in older adults with diabetes was not accounted by a greater 
loss of leg muscle mass. Muscle quality also declined more rapidly in older adults with type 2 
diabetes, suggesting that diabetes may result in functional impairments in muscular function of 
the lower extremities, not necessarily accompanied by loss of muscle mass.  
  Sarcopenia, a status of decreased skeletal muscle mass, is commonly observed in older adults 
as a result of age-related loss of muscle mass. [13-16] In general, it is frequently accompanied by 
lower skeletal muscle strength. However, determinants or risk factors for sarcopenia and low 
muscle strength in older adults have yet to be well identified. This is the first study showing that 
type 2 diabetes is associated with rapid loss of skeletal muscle mass and strength in older adults. 
It confirms previous cross sectional findings of lower muscle strength in individuals with 
diabetes. [8-10] The finding of this longitudinal study strongly suggest that low muscle strength 
in adults with type 2 diabetes is a consequence rather than just a coincidence of type 2 diabetes.   
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 We found discordance between upper and lower extremities regarding diabetes and changes 
in muscle strength over time. In general, a relative preservation of upper extremity strength has 
been observed in the process of aging. [16-17] Our findings are, in fact, consistent with previous 
cross-sectional studies showing decreased skeletal muscle strength at the ankle and knee, but not 
at the wrist and elbow in patients with type 2 diabetes. [8] Andersen et al. reported that upper 
extremity strength was preserved even in long-standing type 1 diabetic patients with greater than 
20 years of duration. [9] They also found that muscle strength was related to the presence and 
severity of peripheral neuropathy in both type 1 and type 2 diabetic patients. [8-9] It is well 
known that lower extremities are predominantly involved in diabetic neuropathy presumably due 
to a length-dependent degeneration of nerve fibers. [18-19] Therefore, skeletal muscle function is 
more likely to be affected by diabetes in the lower extremities than in the upper extremities. In 
our study, overall decline in hand grip strength was less than 1 % per year while knee extensor 
strength declined more than 3 % per year (Figure 3). It is possible that the small changes in hand 
grip strength make it even more difficult to detect any real differences associated with diabetes. 
The exclusion of many participants for year 3 knee extensor strength test may also biased the 
results to the null because proportionally more subjects with diabetes were excluded due to high 
mortality and other reasons (Table 12). We identified 47 participants with diabetes and 181 
without diabetes who were excluded from knee strength test due to contraindications but had 
hand grip strength data at year 3. Among them, declines in hand grip strength were greater in 
older adults with diabetes than those without diabetes (-3.3 ± 6.7 vs. -1.1 ± 6.2 kg, p<0.05, Table 
13), suggesting a strict criteria for knee strength testing might select stronger persons and 
actually obscure the true declines in muscle strength particularly in those with diabetes. 
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Lower extremity strength is essential for maintaining basic physical function, especially 
mobility such as walking and climbing stairs in older adults. It is well established that lower knee 
extensor strength is associated with increased risk of incident mobility limitations. [20-22] 
Although it is unclear whether there is a certain threshold level of leg strength per body weight to 
maintain physical function, it is obvious that lower muscle strength is definitely a risk factor for 
physical disability independent of lower muscle mass itself. [22]  
   The mechanisms for the rapid loss of skeletal muscle strength in older adults with diabetes are 
not known. Neuropathic processes involving motor neurons could affect muscle strength as 
evidenced by close association of muscle strength and severity of diabetic neuropathy in the 
previous cross-sectional observations. [8-9] Electrophysiologic studies showed that muscle 
strength in diabetic patients correlated with fiber density and amplitude of the macro motor unit 
potential, suggesting incomplete reinnervation following axonal loss. [23] Longitudinal studies 
suggest an average loss of compound muscle action potential amplitude at a rate of ~3% per year 
in patients with type 2 diabetes over a 10-year period. [24] Unfortunately muscle strength was 
not assessed in their study. Future research should identify the role of the decrease in motor 
amplitudes on the skeletal muscle strength and quality in subjects with diabetes. 
In our study, adjustments for comorbid conditions such as cardiovascular disease, stroke, 
congestive heart failure, peripheral arterial disease, depression, impaired vision, and renal 
insufficiency attenuated the declines in muscle strength only slightly. It suggests that chronic 
complications of diabetes have a limited role in the declines in the skeletal muscle strength in 
older adults with diabetes. However, we had no reliable assessment of nerve function in our 
study at baseline. It is possible that declines of muscle function may indeed the result of diabetic 
neuropathy.  
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Another potential mechanism would be increased inflammatory cytokines in subjects with 
diabetes. It has been reported that systemic proinflammatory cytokines such as TNF-α and IL-6 
have detrimental effects on muscle mass, strength and physical performance in older adults. [25-
26] In our study, declines in muscle strength in older adults with diabetes are attenuated a little 
by adjusting for TNF-α and IL-6. However, the duration of diabetes and level of glycemic 
control reflected by baseline glycosylated hemoglobin did not explain the declines in muscular 
function (data not shown).  
Our study has several limitations. The study population was well-functioning community-
dwelling black and white men and women who were definitely healthier than those in the typical 
same-aged population. However, the purpose of the Health ABC Study was to identify factors 
related with incident functional limitations in those without disability at baseline. There were 
many drop-outs and only about 70% of participants were completed year three assessments. 
However, we believe that the lost to follow up may underestimate the true decline in muscle 
function in those with diabetes as described above and in table 12 and 13. Finally, we lacked 
information about neuropathy at baseline, which would be closely related with muscular function 
in diabetes. 
   In conclusion, the present study clearly showed an accelerated loss of knee extensor strength 
in older adults with type 2 diabetes. This result confirms previous cross-sectional finding of low 
muscle strength and quality in the same cohort and strongly suggest that poor muscle function in 
older adults is a consequence of diabetes rather than a coincidence.    
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Table 9. Characteristics of participants in the Health, Aging and Body Composition Study by diabetes status 
 Without diabetes 
(n, 1,535) 
With diabetes 
(n, 305)  
P* 
Sociodemographic    
Age (years) 73.4 ± 2.8 73.5 ± 2.7 0.772 
Men (%) 47.7 59.1 <0.001 
Blacks (%) 32.7 51.9 <0.001 
Education < 12 years (%) 19.8 30.9 <0.001 
Anthropometric (Body Composition)   
Height (cm) 166.6 ± 9.2 167.0 ± 9.3 0.312 
Weight (kg) 75.2 ± 14.4 81.0 ± 14.1 <0.001 
BMI (kg/m2) 27.1 ± 4.4 29.0 ± 4.4 <0.001 
Total body fat (%) 33.6 ± 7.6 34.3 ± 7.4 0.050 
Total fat mass (kg) 25.5 ± 8.0 27.9 ± 8.2 <0.001 
Total lean mass (kg) 47.5 ± 10.1 50.7 ± 9.9 <0.001 
Chronic diseases (%)    
Coronary heart disease 15.2 23.7 <0.001 
Congestive heart failure 1.5 2.9 0.094 
Stroke 1.8 1.9 0.860 
Peripheral artery disease 3.0 5.8 0.014 
Knee osteoarthritis 8.4 6.8 0.347 
Depression 11.6 9.7 0.337 
Cancer 21.0 16.6 0.079 
Impaired vision (%) 16.7 25.7 <0.001 
Renal insufficiency (%) 6.0 11.5 0.001 
Subclinical PAD‡ (%) 9.5 19.1 <0.001 
Behavioral factors    
Current smoking (%) 8.5 6.5 0.243 
Alcohol drinking (%) 55.4 38.3 <0.001 
Physical activity, log (kcal/week) 3.7 ± 0.4 3.7 ± 0.4 0.418 
Biochemical     
Fasting glucose (mg/dl) 93.0 ± 9.7 151.8 ± 52.2  <0.001 
HbA1c (%) 6.0 ± 0.5  7.9 ± 1.6 <0.001 
Interleukin-6† (pg/ml) 1.63 (1.12-2.44) 2.16 (1.47-3.08) <0.001 
Tumor necrosis factor-α† (pg/ml) 3.03 (2.35-3.86) 3.41 (2.57-4.37) <0.001 
Data are mean ± SD, proportions, or median (interquartile range). 
* P values from age/sex/race-adjusted logistic regression or linear models comparing participants with and without 
diabetes.  † Wilcoxon rank-sum test for comparison of medians. 
‡ Subclinical peripheral artery disease was defined as ankle arm index < 0.9. 
Table 10. Three-year changes in skeletal muscle strength, mass and quality by diabetes status in the Health, Aging and Body Composition study 
 Without diabetes (n, 1535) With diabetes (n, 305) P‡ 
 Baseline 36 months Change Baseline 36 months Change  
Knee Extensor         
Maximal torque (Nm) 109.1 ± 0.7  96.8 ± 0.7 -12.4 ± 0.5* 111.3 ± 1.5  94.8 ± 1.5 -16.5 ± 1.2* 0.001 
Leg lean mass (kg) 7.52 ± 0.03 7.29 ± 0.03 -0.23 ± 0.01* 7.96 ± 0.07† 7.66 ± 0.07† -0.29 ± 0.03* 0.035 
Specific torque (Nm/kg) 14.4 ± 0.1  13.2 ± 0.1 -1.2 ± 0.1* 14.0 ± 0.2† 12.4 ± 0.2† -1.6 ± 0.2* 0.034 
Hand Grip         
Maximal force (kg) 32.6 ± 0.2  31.3 ± 0.2 -1.3 ± 0.1* 32.1 ± 0.4  30.8 ± 0.4 -1.3 ± 0.3* 0.964 
Arm lean mass (kg) 2.75 ± 0.01 2.70 ± 0.01 -0.06 ± 0.01* 2.92 ± 0.03† 2.83 ± 0.03† -0.08 ± 0.01* 0.025 
Specific force (kg/kg) 12.0 ± 0.1  11.8 ± 0.1 -0.2 ± 0.1* 11.2 ± 0.1†  11.0 ± 0.1† -0.2 ± 0.1 0.757 
Data are adjusted means ± SE from linear models controlling for age, sex, race, and clinic site. 
* P <0.001 between baseline and 36 months within the same group  
† P <0.01 versus those without diabetes at the same time period 
‡ P-values for comparison of 3-yr changes between two groups 
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Table 11. Adjusted 3-year changes in knee extensor strength and muscle quality by diabetes status in the Health, Aging and Body Composition study 
 Without diabetes 
n, 1535 
With diabetes 
n, 305 
P 
Muscle strength (maximal torque, Nm)     
Model 1 -12.4 ± 0.5 -16.5 ± 1.2 0.001 
Model 2 -12.5 ± 0.5 -16.2 ± 1.1 0.001 
Model 3 -12.5 ± 0.5 -15.8 ± 1.1 0.008 
Model 4 
 
-12.7 ± 0.5 -15.6 ± 1.2 0.027 
Muscle quality  (specific torque, Nm/kg)    
Model 1  -1.22 ± 0.07 -1.57 ± 0.15 0.034 
Model 2 -1.20 ± 0.06 -1.69 ± 0.14 0.001 
Model 3 -1.21 ± 0.06 -1.64 ± 0.14 0.006 
Model 4 -1.24 ± 0.06 -1.63 ± 0.15 0.019 
Data are adjusted means ± standard error  
Model 1: adjusted for sex, race, age, and clinic site 
Model 2: additionally adjusted for body mass index, baseline strength or quality, and changes in leg lean mass  
Model 3: additionally adjusted for coronary heart disease, stroke, congestive heart failure, peripheral artery disease, knee osteoarthritis, cancer, depression, impaired vision, 
renal insufficiency, and subclinical peripheral artery disease (ankle arm index <0.9) 
Model 4: additionally adjusted for cytokines (log transformed IL-6 and TNF-α)  
 
 
 
Table 12. Baseline characteristics of completers and incompleters in the Health, Aging and Body 
Composition Study  
 Completers 
n, 1840 (70.3%) 
Incompleters 
n, 778 (29.7%) 
P 
Age (years) 73.4 ± 2.8 73.9 ± 2.9 <0.001 
Men (%) 50.3 53.5 0.135 
Blacks (%) 36.1 49.4 <0.001 
BMI (kg/m2) 27.2 ± 4.5 27.7 ± 5.3 0.010 
Diabetes (%) 16.6 23.1 <0.001 
Coronary heart disease (%) 16.5 22.9 <0.001 
Congestive heart failure (%) 1.7 5.8 <0.001 
Stroke (%) 1.8 4.4 <0.001 
Peripheral artery disease (%) 3.4 7.2 <0.001 
Impaired vision (%) 18.1 24.4 <0.001 
Renal insufficiency (%) 7.0 14.2 <0.001 
Subclinical PAD (%) 11.0 18.3 <0.001 
Knee extensor strength (Nm) 109.5 ± 38.2 98.6 ± 35.6 <0.001 
Hand grip strength (kg) 32.5 ± 10.8 30.8 ± 10.8 <0.001 
Reasons for incompletion (n, %)    
   Death - 146 (18.8)  
   Home examination*   - 245 (31.5)  
   Proxy interview* - 57 (7.3)  
   Contraindications for knee strength test† - 191 (24.6)  
   Missing data for DXA body composition - 51 (6.6)  
   Missed contact - 77(9.9)  
   Withdrawal  11 (1.4)  
Data are mean ± SD or proportions,  
* The main reasons for home examination and proxy interview were participant’s disabilities and/or 
institutionalization.  
† Contraindications for knee strength test include uncontrolled hypertension, history of stroke or aneurism in the 
brain, bilateral knee joint replacement, and severe bilateral knee pain 
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Table 13. Characteristics of incompleters in the Health, Aging and Body Composition Study by 
diabetes status  
 Without diabetes 
n, 598 
With diabetes 
n, 180 
P 
Incompletion rate (% of initial participants) 28.0 37.1 <0.001 
Age (years) 74.0 ± 2.9 73.7 ± 3.1 0.275 
Men (%) 54.7 49.4 0.217 
Blacks (%) 45.7 61.7 <0.001 
BMI (kg/m2) 27.3 ± 5.2 29.2 ± 5.4 <0.001 
Coronary heart disease (%) 19.7 33.3 <0.001 
Congestive heart failure (%) 4.2 11.1 <0.001 
Stroke (%) 3.7 6.7 0.086 
Impaired vision (%) 22.1 31.8 0.008 
Renal insufficiency (%) 12.0 21.2 0.002 
Subclinical PAD (%) 17.5 21.0 0.312 
Knee extensor strength (Nm) 99.7 ± 36.3 94.9 ± 32.7 0.125 
Hand grip strength (kg) 30.8 ± 11.1 30.6 ± 10.0 0.810 
Changes in hand grip strength (kg)* -1.1 ± 6.2 -3.3 ± 6.7 0.036 
Data are mean ± SD or proportions  
* Based on available data (n=181 for those without diabetes, and 47 for those with diabetes), year 3 hand grip 
strength was measured either at clinic or at home  
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Figure 3. Relative changes in skeletal muscle strength 
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4.  ARTICLE THREE: ACCELERATED LOSS OF SKELETAL MUSCLE MASS IN 
OLDER ADULTS WITH DIABETES MELLITUS: THE HEALTH, AGING AND BODY 
COMPOSITION STUDY 
 
 
4.1  ABSTRACT 
 
Loss of muscle mass (sarcopenia) is common in older adults. The aim of this study was 
to examine longitudinal changes of body composition in older adults in relation to diabetes (DM) 
status at baseline. We assessed body composition annually by dual energy X-ray absorptiometry 
over a five year period in 2,675 older adults in the Health, Aging and Body Composition Study. 
Diagnosed DM (n, 402) was identified by self-report or use of hypoglycemic agents. 
Undiagnosed DM (n, 226) was defined by fasting plasma glucose ≥ 126 mg/dL or 2-hour post-
challenge plasma glucose ≥ 200 mg/dL among those without diagnosed DM. We also measured 
body fat distribution and thigh muscle area by computed tomography at the L4-L5 disc space and 
mid-thigh at baseline and 5 years later. Longitudinal regression models were fit to examine the 
impact of diabetes on the annual changes in body composition adjusting for age, sex, race, clinic 
site, baseline body composition, and weight loss intention assessed by questionnaire at each year. 
Both diagnosed DM and undiagnosed DM showed accelerated loss of appendicular lean mass 
and trunk fat mass compared with non-diabetic older adults. Furthermore, thigh muscle area 
declined two times faster in older women with diagnosed DM and undiagnosed DM than non-
diabetic women. These findings are independent of baseline body composition, weight change, 
and inflammatory cytokines. In conclusion, diabetes is associated with accelerated loss of 
skeletal muscle mass in older adults. Older women with undiagnosed DM are at especially high 
risk for loss of skeletal muscle mass.  
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4.2    INTRODUCTION 
 
 
Weight loss occurs frequently in older adults and it has been associated with increased 
morbidity and mortality. [1-3] In older persons, weight loss is strongly associated with loss of 
lean mass although they would be expected to lose both lean and fat mass. [4-6] Even in weight 
stable older adults, there is a background loss of lean mass. [7] An excessive loss of lean mass 
would result in loss of skeletal muscle strength, mobility limitations, disability, and eventually 
high mortality in older adults. [8-11] However, little is known about the causes or risk factors 
associated with weight loss and loss of lean mass in older adults. Obesity and changes in body 
composition, especially accumulation of abdominal fat, is an important risk factor for type 2 
diabetes. [12-14] But, the changes in weight and body composition after the development of 
diabetes are not well studied.   
         In a large, ongoing cohort study of older black and white men and women, the Health, 
Aging, and Body Composition (Health ABC) Study, we assessed changes in total mass, fat free 
non-bone lean mass, and fat mass over 5 years with precise measures of total and regional body 
composition with state of the art techniques such as dual-energy X-ray absorptiometry (DXA) 
and computed tomography (CT). The aim of this study was to investigate longitudinal changes in 
total and regional body composition in relation to baseline diabetes status in well-functioning 
community-dwelling older adults. We hypothesized that older adults with type 2 diabetes, 
particularly those with undiagnosed diabetes, might show an accelerated loss of skeletal muscle 
mass. 
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4.3   METHODS 
 
4.3.1   Participants 
 
The Health ABC Study is a longitudinal investigation of the relation between changes in 
body composition and functional decline with aging. The study cohort consisted of 3,075 well 
functioning black and white men and women aged 70 to 79 years (men: 48%, black: 42%). 
Whites were recruited from a random sample of Medicare beneficiaries residing in ZIP codes 
from the metropolitan areas surrounding Pittsburgh, Pennsylvania and Memphis, Tennessee. 
Blacks were recruited from all age-eligible residents in these geographic areas. Eligibility criteria 
included: age 70 to 79 years old in the recruitment period from March 1997 to July 1998; self-
report of no difficulty walking one-quarter of a mile or climbing 10 steps without resting; no 
difficulty performing basic activities of daily living; no reported use of a cane, walker, crutches 
or other special equipment to ambulate; no history of active treatment for cancer in the prior 3 
years; and no plan to move out of the area in the next 3 years.  
Of the 3,075 participants, 2,675 older adults (87%) who had body composition assessments 
by DXA at baseline and at least one more annual follow-up were included for this study. The 
changes in body composition were assessed for 11,873 person years. The average follow up 
duration was 4.4 years. The majority of participants took annual DXA scans for more than 4 
years [1,961 (73%) for 6 years, 273 (10%) for 5 years, 157 (6%) for 4 years]. The main reason 
for lost to follow up examination was death of participants (519, 19 %) through year 6. A 
subgroup of participants (1,629, 53% of original cohort) who had assessment of mid-thigh 
muscle area by CT at both year 1 (baseline) and year 6 was analyzed separately.  
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4.3.2 Assessment of diabetes 
 
Participants were considered as having diagnosed diabetes if they had either a report of 
physician diagnosed diabetes mellitus or current use of a hypoglycemic medication. We 
performed 75g oral glucose challenge test for all participants except those with diagnosed 
diabetes. Undiagnosed diabetes was defined by a fasting plasma glucose concentration level of 
126 mg/dL or greater (≥ 7.0 mmol/L), or a 2-hour post-challenge plasma glucose level of 200 
mg/dL or greater (≥ 11.1 mmol/L) among those without diagnosed diabetes. The average 
duration of diabetes for diagnosed diabetes was 13.3 ± 10.9 years from the time of diagnosis. 
Plasma glucose was measured using an automated glucose oxidase reaction (Vitros 950 analyzer, 
Johnson and Johnson, Rochester, NY) and a glycosylated hemoglobin (HbA1c) was measured by 
enzymatic method (Bio-Rad, Hercules, CA).  
 
4.3.3  Body composition by DXA 
 
Body weight and height were measured in a hospital gown and without shoes on a 
calibrated balance beam scale and stadiometer, respectively, and a body mass index (BMI) in 
kg/m2 was calculated.  We used fan-beam dual energy x-ray absorptiometry (model QDR 4500, 
software version 8.21, Hologic, Bedford, MA) to measure total body mass and body composition. 
Total body fat and lean mass were measured and separated into trunk and appendicular 
components. Bone mineral content was subtracted from the total and regional lean mass to define 
total and regional non-bone lean mass. Appendicular lean mass was calculated as the sum of lean 
soft tissue (non-fat, non-bone) mass in the arms and legs, which represents primarily skeletal 
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muscle mass in the extremities. The validity and reproducibility of the body composition data in 
the Health ABC Study were reported previously. [15-17] Quality-assurance measures included 
the use of a body composition phantom for calibration and annual assessment for potential site 
differences or drift over time. 
 
 
4.3.4   Body composition by CT 
 
Axial CT scans at the abdomen and mid-thigh level was obtained at baseline (year 1) and 
five years later (year 6). CT images were acquired either in Pittsburgh (9800 Advantage; General 
Electric, Milwaukee, WI) or Memphis (Somaton Plus [Simens, Iselin, NJ] or PQ2000S [Picker, 
Cleveland, OH]). Skeletal muscle and adipose tissue areas of the thigh were calculated from the 
axial CT images using proprietary IDL development software (RSI Systems, Boulder, CO). The 
adipose tissue interspersed between muscle, termed intermuscular fat, was distinguished from the 
subcutaneous fat by manually drawing a line along the deep fascial plane surrounding the thigh 
muscles. We used mid-thigh muscle cross sectional area as an indicator of skeletal muscle mass. 
To ensure the reproducibility and quality of the repeated CT scans, we performed a strict quality 
control: scans with any artifacts or poor quality were removed; abdominal scans obtained at or 
above L3/L4 level or at or below L5/S1 level were removed; mid-thigh scans obtained from 
different leg or a slice location on the femur greater than 2 cm of the baseline scan were also 
removed.  
 
 
 69
4.3.5 Inflammatory cytokines 
 
Interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) were measured in duplicate using 
an untrasensitive enzyme-linked immunosorbent assay (R&D Systems, Minneapolis, Minn). The 
lower limit of detection was less than 0.10 pg/ml for IL-6 and 0.18 pg/ml for TNF-α, with 
coefficients of variation of 6.3% and 16.0%, respectively. 
 
4.3.6 Statistical analysis 
 
Baseline characteristics of the cohort are presented separately for three groups defined by 
baseline diabetes status. Analysis of variance tests, Chi-square tests, or Kruskal Wallis tests were 
used to examine differences in the descriptive characteristics of the study population. The 
longitudinal changes in body composition were analyzed by the generalized estimating equations 
(with SAS Version 8.1 Proc Genmod) developed by Liang and Zeger (18-19). This method 
simultaneously examines the cross-sectional relation between each independent variable and 
body composition and the longitudinal relation between these variables and changes in body 
composition over time. Included in the models are potential confounding factors which are 
associated with body composition and its changes over time. The initial model included age, sex, 
race, clinic site, baseline body composition, weight loss intention at each year, two dummy 
variables for diagnosed DM and undiagnosed DM, examination year (Yr) as a time-dependent 
covariate, and cross-product terms between Yr and two dummy variables for diabetes 
(Yr*diagnosed DM, Yr*undiagnosed DM) to assess changes in body composition over time 
between groups. Interactions with sex, race, clinic site with diabetes variables (eg. sex*diagnosed 
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DM*Yr) were assessed. There was no significant interaction effect (p<0.10) between sex, race, 
or clinic site with diabetes variables on the changes in body composition. The final model 
included changes in body weight at each examination year as time-dependent covariates to 
examine effects of diabetes on the changes in each body composition parameters adjusting for 
body weight changes.  
         For the body composition data obtained from CT scan, changes in abdominal subcutaneous 
fat, visceral fat, thigh subcutaneous fat, thigh intermuscular fat, and thigh muscle cross-sectional 
area were calculated in both absolute terms (year 6 value minus year 1 value) and relative terms 
(percent change from baseline). Differences between groups were assessed by general linear 
models controlling for age, sex, race, clinic site, and baseline values when using absolute 
changes. We found a significant interaction effect (p<0.05) of sex and diabetes variables on the 
changes of thigh muscle area. Therefore, further analyses were stratified by sex for CT data. 
Additional adjustments were made for baseline body composition, weight change, IL-6 and 
TNF-α. We used Bonferroni correction methods for multiple comparisons between groups. A p-
value of <0.05 was accepted as statistically significant. The analyses were performed using SPSS 
(version 12.0.0, SPSS Inc., Chicago, IL) and SAS (version 8.1, SAS Institute, Inc., Cary, NC). 
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4.4  RESULTS 
 
Among the 2,675 participants with follow-up body composition assessments with DXA, 
402 (15.0%) had diagnosed diabetes at baseline. Two hundred twenty six older adults (8.5%) 
were undiagnosed diabetes identified by a result of oral glucose challenge test. Those with either 
diagnosed or undiagnosed diabetes were more likely to be men, black, and had higher BMI, total 
body mass (weight), total fat and total lean mass than those without diabetes (Table 1). As 
expected, coronary heart disease, congestive heart failure, stroke, impaired vision, and renal 
insufficiency were more prevalent in those with diagnosed diabetes. IL-6 and TNF-α levels were 
significantly higher in older adults with either diagnosed or undiagnosed diabetes (Table 14).  
Total body mass (weight), total and appendicular lean mass declined with aging in all three 
groups. However, the slopes of decline were steeper in those with undiagnosed diabetes (Figure 
4). Total fat mass increased or maintained in those without diabetes and those with diagnosed 
diabetes, whereas it declined slightly in those with undiagnosed diabetes. The annual changes in 
each body composition parameters adjusting for age, sex, race, clinic site, baseline body 
composition, and weight loss intention at each year are summarized in Table 15. In older adults 
with undiagnosed diabetes, the loss of total and appendicular lean mass were significantly greater 
than those without diabetes (p<0.01). They also showed greater loss of trunk lean mass (p<0.01), 
total and trunk fat mass (p<0.05) compared with non-diabetic older adults. Those with diagnosed 
diabetes showed greater loss of appendicular lean and trunk fat mass compared with non-diabetic 
older adults (p<0.05). Table 16 shows disproportional changes in body composition adjusting for 
body weight changes. In all three groups, lean body mass decreased and fat mass increased over 
time after adjusting for weight change. In other words, there were significant loss of lean mass 
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and accumulation of fat mass accounting for the changes in overall body weight. Furthermore, 
the declines of total and appendicular lean mass in older adults with undiagnosed diabetes were 
greater than non-diabetic older adults adjusting for age, sex, race, clinic site, baseline body 
composition, weight loss intention, and changes in body weight. In older adults with diagnosed 
diabetes, trunk lean and fat mass were slightly increased when the changes in overall weight 
were accounted for (Table 16). 
Five year changes in body composition assessed by CT scan were summarized in Table 17. 
The changes in abdominal subcutaneous fat, visceral fat, thigh subcutaneous fat, and 
intermuscular fat area were not different between groups. However, thigh muscle area was 
decreased more rapidly in older women with either diagnosed or undiagnosed diabetes than those 
without diabetes (Table 17). There was a significant interaction effect of sex and diabetes status 
on the changes in thigh muscle area (p=0.044). When the changes were assessed in relative term, 
older women with either diagnosed or undiagnosed diabetes showed twofold excess declines in 
thigh muscle area than non-diabetic women (Figure 5). In women, adjustments for baseline 
weight, weight change over 5 years, IL-6, and TNF-α slightly attenuated the rapid declines in 
thigh muscle area (Table 18). Older women with either diagnosed or undiagnosed diabetes 
remained to show about twofold greater loss of thigh muscle area even in fully adjusted model.  
 
 73
4.5    DISCUSSION 
  
We found rapid declines in appendicular lean mass in older adults with diabetes, especially 
in undiagnosed cases. Furthermore, these declines were independent of changes in body weight 
itself, suggesting an excess and accelerated loss of skeletal muscle mass in older adults with 
diabetes. The CT data confirmed rapid loss of thigh muscle mass in older adults with diabetes 
although it was significant only in women.  
In older adults, weight loss is a profound marker for devastating consequences such as 
physical disability and high mortality risk. [1-3] Adverse outcomes of weight loss in older adults 
may be attributable to an excessive loss of lean mass and resultant sarcopenia. [6] The findings 
of our study clearly show that diabetes in older adults is associated with excessive loss of 
appendicular lean mass, which represents loss of primarily skeletal muscle mass. Interestingly, 
older adults with undiagnosed diabetes are particularly at high risk for loss of lean mass. There is 
a paucity of literature in this area. To our knowledge, this is the first study showing excessive 
loss of lean mass in older adults with diabetes. Diabetes mellitus was one of factors associated 
with weight loss in 4,714 community-dwelling adults aged 65 and older in the Cardiovascular 
Health Study (CHS). [3] However, lean body mass was not assessed in CHS and we did not 
know which body composition was responsible for weight loss in older adults with diabetes.  
It has been known that changes in lean body mass are strongly coupled with changes in body 
weight. [4-5, 21] But, in older adults, significantly more lean mass is lost with weight loss than is 
gained with weight gain. [6] Even in weight stable individuals, there is a background loss of lean 
mass suggesting that loss of lean mass or sarcopenia is a progressive process with aging. [7] 
Excessive loss of lean mass has been observed particularly in elderly men. In our study, there 
 74
was no interaction effect of sex and baseline diabetes status on the changes in total and 
appendicular lean mass assessed by DXA. We found the same results even if the analyses were 
stratified by sex for changes in lean mass assessed by DXA (data not shown). However, we 
found a significant interaction effect of sex and diabetes status on the changes in thigh muscle 
area assessed by CT scan. Older women with either diagnosed or undiagnosed diabetes showed 
about twofold excessive loss of thigh muscle area compared with non-diabetic women. In fact, 
the rate of thigh muscle decline in older women with diabetes was almost the same as older men 
suggesting that women with diabetes lost beneficial effect of female sex on preserving lean mass 
(Figure 5). Previous studies showed that loss of lean mass was greater in men than women. [6, 
20-21] Higher background decline rate of thigh muscle area in older men without diabetes may 
make it difficult to detect the changes associated with diabetes. It is also possible that survival 
bias or selection bias for year 6 CT measurement may obscure the true association, particularly 
in men. In our cohort, lost to follow-up for year 6 CT measurement was non-random because 
older adults with diabetes had higher mortality rate, especially in men (5-yr mortality rates: 
21.4% vs 32.5% vs 30.5% for men, p=0.001 and 12.6% vs 13.0% vs 21.2% for women, p=0.008; 
for those without diabetes, those with undiagnosed diabetes, and those with diagnosed diabetes, 
respectively). Failure to return to the clinic visit due to disability and institutionalization was also 
higher in older adults with diabetes. Our previous report on the changes of muscle strength in the 
same population suggested that this differential follow-up rate or non-random missing biased the 
result to the null. The longitudinal analyses by generalized estimating equation have advantages 
for reducing selection bias because it uses all available data from annual measurements of body 
composition. Generalized estimating equation allows missing measurements during follow-up 
instead of eliminating the individuals with missing data. [22-23] 
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From the DXA data, an excessive loss of appendicular lean mass was evident in both 
diagnosed and undiagnosed diabetes. Interestingly, those with undiagnosed diabetes showed the 
greatest decline in appendicular lean mass suggesting undiagnosed diabetes is a significant risk 
factor for loss of muscle mass and sarcopenia. Long duration of exposure to diabetes (average 
13.3 years) may already affect the baseline body composition in older adults with diagnosed 
diabetes, which make it difficult to detect any further changes in body composition. It is also 
possible that treatment effects can modify the association of diabetes and changes in body 
composition. For example, insulin therapy usually results in weight gain. A subgroup analyses 
for the influence of various treatments in older adults with diagnosed diabetes will be an 
interesting topic and we are now in progress to answer this question.  
The reason for an accelerated loss of lean mass in older adults with undiagnosed diabetes is 
unknown for now. Increased inflammatory cytokines are possibly involved in this process, 
because diabetes has been known to be subclinical inflammatory status [24-25] and elevated 
inflammatory cytokines are associated with muscle mass and physical performance in older 
persons. [26-28] However, in our study, the adjustments for IL-6 and TNF-α only slightly 
attenuated the declines in thigh muscle area. It is also possible that older adults with undiagnosed 
diabetes were trying to lose weight intentionally because we informed the result of oral glucose 
challenge test to the participants in the Health ABC Study. However, excess loss of lean mass 
was evident even after adjusting for the weight loss intention assessed by questionnaire at each 
examination year. In fact, weight loss intention did not result in actual weight loss in our cohort 
(data not shown).  
It can be postulated that metabolic abnormalities of undiagnosed diabetes affect negatively 
on muscle mass. Metabolic derangements in diabetes relate mostly to hyperglycemia and to the 
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catabolic state of the patient such as urinary loss of glucose and calories, muscle breakdown due 
to protein degradation and decreased protein synthesis. [29] Unexplained weight loss is, in fact, 
one of common manifestations of undiagnosed diabetes mellitus. To test whether loss of lean 
mass were related to the level of hyperglycemia, we are going to investigate the association 
between level of glycosylated hemoglobin (HbA1c) and changes in lean mass within this cohort.  
The results of this study may have important public health implication. The prevalence of 
diabetes is increasing especially in older adults and about one third of diabetes is remained 
undiagnosed. [30-32] If older adults with undiagnosed diabetes were left untreated they would be 
at high risk for weight loss, particularly loss of lean mass. It seems highly likely that accelerated 
loss of lean mass in older adults with diabetes might be related to muscle strength loss, 
functional limitations, and physical disability. [33-36] Future research should find factors related 
with accelerated loss of lean mass in older adults with diabetes to develop strategies to prevent 
sarcopenia in this high risk population. [37-38] In conclusion, diabetes mellitus is associated 
with accelerated loss of skeletal muscle mass in older adults. Those with undiagnosed diabetes 
are at especially high risk for loss of skeletal muscle mass.  
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Table 14. Characteristics of participants by baseline diabetes status  
 Without diabetes 
(n,2047) 
Undiagnosed 
diabetes (n, 226)  
Diagnosed diabetes 
(n, 402) 
P* 
Sociodemographic     
Age (years) 73.6 ± 2.9 73.7 ± 2.8 73.6 ± 2.7 NS 
Men (%) 47.6 55.8 55.5 <0.001 
Blacks (%) 36.7 42.0 57.7 <0.001 
Body Composition    
BMI (kg/m2) 26.8 ± 4.6 28.5 ± 4.8 29.1 ± 4.7 <0.001 
Total body mass (kg) 74.2 ± 14.4 79.9 ± 15.8 81.2 ± 14.0 <0.001 
Total lean mass (kg) 45.9 ± 9.8 49.1 ± 10.3 50.4 ± 9.3 <0.001 
    Trunk lean 23.1 ± 4.8 24.8 ± 5.1 25.3 ± 4.7 <0.001 
    Appendicular lean 19.8 ± 4.9 21.1 ± 5.1 21.9 ± 4.6 <0.001 
Total fat mass (kg) 26.0 ± 8.4 28.4 ± 9.0 28.5 ± 8.7 <0.001 
    Trunk fat 12.9 ± 4.6 14.9 ± 5.3 15.0 ± 5.0 <0.001 
    Appendicular fat 12.6 ± 4.5 13.0 ± 4.6 12.8 ± 4.3 NS 
Chronic diseases      
Coronary heart disease (%) 18.0 24.3 27.1 <0.001 
Congestive heart failure (%) 2.0 5.8 4.5 <0.001 
Stroke (%) 7.3 6.6 11.2 <0.05 
Knee osteoarthritis (%) 8.5 7.5 7.2 NS 
Depression (%) 11.9 11.1 11.2 NS 
Cancer (%) 19.8 22.1 16.2 NS 
Impaired vision (%) 18.6 18.2 27.4 <0.001 
Renal insufficiency (%) 8.3 7.5 17.4 <0.001 
Behavioral factors     
Current smoking (%) 10.4 8.0 9.0 NS 
Alcohol drinking (%) 53.2 55.8 30.8 <0.001 
Physical activity,  
(kcal/kg/week) 87.2 ± 68.7 77.9 ± 62.3 75.0 ± 75.0 0.002 
Biochemical      
Fasting glucose (mg/dl) 92.6 ± 9.4 125.7 ± 39.5 154.1 ± 58.6 <0.001 
HbA1c (%) 6.0 ± 0.5 6.9 ± 1.3 8.0 ± 1.6 <0.001 
Interleukin-6† (pg/ml) 1.72 (1.17-2.62) 2.10 (1.38-3.08) 2.16 (1.52-3.19) <0.001 
Tumor necrosis factor-α† 
 (pg/ml) 
3.08 (2.38-3.95) 3.28 (2.49-4.34) 3.46 (2.58-4.42) <0.001 
Data are mean ± SD, proportions, or median (interquartile range). 
* P values from analysis of variance or chi-square tests.  † Kruskal Wallis tests. 
 78
Table 15. Annual changes in body composition variables assessed with dual-energy X-ray 
absorptiometry by baseline diabetes status  
 Without diabetes 
(n,2047) 
Undiagnosed diabetes 
(n, 226) 
Diagnosed diabetes 
(n, 402) 
Total body mass (g/yr) -189 (23) -441 (80)** -279 (72) 
Total lean mass (g/yr) -196 (10) -340 (37)** -216 (29) 
Trunk lean (g/yr) -42 (6) -105 (22)** -27 (16) 
Appendicular lean (g/yr) -149 (5) -225 (20)** -184 (16)* 
Total fat mass (g/yr)  27 (16) -93 (53)* -61 (53) 
Trunk fat (g/yr) 46 (10) -41 (35)* -32 (32)* 
Appendicular fat (g/yr) -15 (7) -49 (24) -27 (24) 
Data are β-coefficients (SE) estimated by generalized estimating equations adjusting for age, sex, race, clinic site, 
baseline body composition, and weight loss intention at each year 
* p < 0.05, ** p < 0.01 versus those without diabetes 
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Table 16. Disproportional changes in body composition variables after adjusting for changes in 
body weight by baseline diabetes status  
 Without diabetes 
(n,2047) 
Undiagnosed diabetes 
(n, 226) 
Diagnosed diabetes 
(n, 402) 
Total lean mass (g/yr) -125 (7) -187 (25)* -101 (19) 
Trunk lean (g/yr) -9 (5) -33 (18) 27 (13)* 
Appendicular lean (g/yr) -113 (4) -149 (14)* -130 (11) 
Total fat mass (g/yr) 164 (7) 204 (23) 155 (20) 
Trunk fat (g/yr) 126 (5) 135 (18) 95 (14)* 
Appendicular fat (g/yr) 42 (4) 74 (14)* 60 (12) 
Data are β-coefficients (SE) estimated by generalized estimating equations adjusting for age, sex, race, clinic site, 
baseline body composition, weight loss intention at each year, and changes in body weight  
* p < 0.05 versus those without diabetes.  
 
 
 
 Without diabetes  
Undiagnosed diabetes 
 
Diagnosed diabetes 
 
 Baseline Change % change Baseline Change % change Baseline Change % change 
Men   (n, 606)   (n, 68)   (n, 120)  
Abdomen           
Subcutaneous fat area (cm2) 223.8 ± 3.5 -14.0 ± 1.6 -5.8 ± 0.8 246.2 ± 12.3 -16.4 ± 4.8 -7.8 ± 2.0 250.2 ± 8.4* -14.2 ± 5.2 -5.1 ± 2.0 
Visceral fat area (cm2)  152.9 ± 2.8 -1.1 ± 1.8 -1.0 ± 1.2 187.4 ± 10.1* 3.6 ± 6.8 1.9 ± 4.0 173.0 ± 6.8* -0.1 ± 5.2 3.5 ± 3.0 
Mid-thigh          
Subcutaneous fat area (cm2)  95.8 ± 1.6 -2.0 ± 0.7 -2.0 ± 0.8 94.4 ± 4.7 -2.5 ± 2.4 -3.6 ± 2.8 93.6 ± 3.4 1.2 ± 2.0 0.8 ± 2.0 
Intermuscular fat area (cm2) 18.7 ± 0.4 6.0 ± 0.2 48.9 ± 2.4 21.1 ± 1.5 6.4 ± 0.7 41.4 ± 4.9 21.6 ± 1.6 7.6 ± 0.6* 51.6 ± 4.1 
Muscle area (cm2) 262.5 ± 1.7 -12.9 ± 0.7 -4.8 ± 0.3 271.7 ± 5.2 -18.2 ± 2.7 -6.4 ± 0.9 273.5 ± 3.8* -14.4 ± 2.0 -5.2 ± 0.7 
    Muscle attenuation (HU) 37.7 ± 0.3 -0.9 ± 0.2 -1.0 ± 0.6 36.8 ± 0.7 -1.7 ± 0.6 -4.3 ± 1.7 37.5 ± 0.2 -1.7 ± 0.6 -3.2 ± 1.6 
Women  (n, 684)   (n, 57)   (n, 94)  
Abdomen           
Subcutaneous fat area (cm2) 327.3 ± 4.6 -24.0 ± 2.0 -7.1 ± 0.8 358.9 ± 15.1 -26.8 ± 6.4 -8.1 ± 1.9 371.8 ± 11.6* -27.2 ± 7.6 -7.0 ± 1.9 
Visceral fat area (cm2)  122.6 ± 2.1 -9.5 ± 1.3 -7.6 ± 1.0 157.3 ± 8.9* -8.6 ± 3.9 -7.4 ± 3.0 165.7 ± 6.7* -19.6 ± 4.7* -10.4 ± 3.0 
Mid-thigh          
Subcutaneous fat area (cm2)  211.5 ± 3.4 -6.9 ± 1.2 -2.7 ± 0.6 224.6 ± 12.5 -8.2 ± 5.0 -1.6 ± 2.3 218.2 ± 9.4 -5.6 ± 4.5 -0.8 ± 2.2 
Intermuscular fat area (cm2) 19.3 ± 0.5 3.4 ± 0.2 30.4 ± 1.6 22.3 ± 1.5 3.5 ± 1.0 24.3 ± 5.3 25.4 ± 1.4* 3.7 ± 0.7 24.8 ± 3.9 
Muscle area (cm2) 181.7 ± 1.3 -4.9 ± 0.5 -2.5 ± 0.3 194.1 ± 4.7* -12.0 ± 2.8* -5.5 ± 1.3* 206.8 ± 3.4* -12.0 ± 1.9* -5.5 ± 0.9* 
    Muscle attenuation (HU) 34.4 ± 0.3 -0.3 ± 0.2 0.7 ± 0.7 32.9 ± 0.9 -0.8 ± 0.8 -1.4 ± 0.3 33.5 ± 0.7 -0.4 ± 0.6 -1.7 ± 0.3 
Table 17. Five-year changes in body composition variables assessed with computerized tomography by baseline diabetes status, stratified by sex 
Data are adjusted means ± SE from general linear models adjusting for age, sex, race, and clinic site. 
* P <0.05 versus those without diabetes, after Bonferroni correction for multiple comparisons 
81 
 Table 18. Multivariate models for 5-year changes in thigh muscle cross sectional area by baseline 
diabetes status in older women 
 Without diabetes 
 
Undiagnosed 
diabetes  
Diagnosd diabetes 
 
P 
Model 1 -5.1 (0.5) -11.7 (1.8)* -11.1 (1.4)* <0.001 
Model 2 -5.2 (0.5) -11.3 (1.8)* -10.6 (1.4)* <0.001 
Model 3 -5.3 (0.4) -10.8 (1.4)* -10.0 (1.1)* <0.001 
Model 4 -5.2 (0.4) -10.6 (1.5)* -9.3 (1.2)* <0.001 
Data are adjusted means (SE)  
Model 1: adjusted for age, race and clinic site 
Model 2: additionally adjusted for baseline body weight 
Model 3: additionally adjusted for changes in body weight  
Model 4: additionally adjusted for interleukin-6 and tumor necrosis factor-α 
* p <0.01 versus those without diabetes, after Bonferroni correction for multiple comparison. 
 
 
 82
 Figure 4. Longitudinal changes in body composition by baseline diabetes status. 
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 Figure 5. Relative changes in thigh muscle area by baseline diabetes status. 
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 5.    DISCUSSION 
 
This cross-sectional and longitudinal study of the association between diabetes in older 
adults and skeletal muscle phenotypes including muscle quantity and function clearly shows that 
diabetes is a risk factor for loss of muscle mass and strength. We demonstrated not only a cross-
sectional association but also dose-response effects of diabetes duration and severity, reflected 
by high glycosylated hemoglobin (A1c), on skeletal muscle quality defined as maximal strength 
per unit muscle mass. Furthermore, this cross-sectional association was confirmed by 
longitudinal data showing a temporal relationship between diabetes and loss of muscle mass and 
strength. 
        The Health, Aging, and Body Composition (Health ABC) Study is an ideal cohort to 
examine the impact of diabetes on body composition and muscle strength because we measured 
body composition annually up to 6 years by state of the art techniques such as dual-energy X-ray 
absortiometry and computed tomography. We were able to assess muscle quality, which 
represents contractile capacity of skeletal muscle groups because maximal muscle strength was 
measured quantitatively by isometric and isokinetic dynamometer. Moreover, we could identify 
many undiagnosed diabetes by a 75g-oral glucose challenge test performed for all participants 
without history of diabetes. We also collected extensive information on baseline 
sociodemographic variables, past medical history (adjudicated by self-reported physician-
diagnosed diseases, medication use, and clinic assessment), and various lifestyle factors 
(smoking, alcohol drinking, physical activity, and intention to lose weight, etc.) in the Health 
ABC Study. Therefore we were able to adjust potential factors which might confound the 
associations between diabetes and muscle mass and strength in our cohort.  
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 To our knowledge, this is the first study showing that diabetes is clearly associated with 
rapid loss of muscle mass and strength in older adults. Our findings have important public health 
implications because the prevalence of diabetes is continuously increasing especially in older 
population and diabetes in older adults is an established risk factor of developing functional 
disability and mortality.  
 
5.1   MUSCLE MASS IN DIABETES 
 
        In this study, older adults with diabetes had a greater amount of muscle mass in their arm 
and leg than those without diabetes at baseline. But it is just because persons with diabetes had 
higher BMI. Although older adults with diabetes had greater muscle mass in absolute amount, 
their muscle mass may be similar or possibly lower in relative terms than non-diabetic older 
adults. Previous cross-sectional study of the Health ABC cohort revealed some distinctive 
patterns of body composition in older adults with diabetes. [1] Older men and women with 
diabetes had higher % body fat, higher visceral and intermuscular fat, and lower muscle 
attenuation value than non-diabetic counterparts. Many older adults with diabetes are likely to 
have “sarcopenic obesity” because the proportion of fat free mass (% fat free mass) is lower than 
non-diabetic older adults. [1] It is also possible that DXA may overestimate the actual muscle 
mass in those with diabetes. DXA could not distinguish adipose tissue infiltrated within muscle 
mass from actual muscle mass. Lower muscle attenuation by CT scan may indirectly support this 
possibility because reduced muscle attenuation is a marker of an augmented fat infiltration 
within muscle. [2-3] Furthermore, lower muscle attenuation is associated with lower specific 
torque (maximal torque per unit muscle mass) in the Health ABC Study. [4]  
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 Sarcopenia was originally defined by Baumgartner et al. [5] as appendicular skeletal muscle 
mass/height-squared (aLM/ht2 in kg/m2) being less than two standard deviations below the mean 
of a young reference group. But, it has been argued that alternative definition of sarcopenia such 
as appendicular lean mass adjusted for height and body fat mass by residuals is more strongly 
associated with lower extremity functional limitations. Therefore, as Newman et al. [6] 
suggested, fat mass should be considered in estimating sarcopenia especially in women and in 
overweight and obese individuals. In fact, Baumgartner’s definition could not identify sarcopenic 
subjects in obese elderly subjects when 12-15% of obese people were classified as sarcopenia by 
Newman’s definition. Furthermore, sarcopenia by Newman’s definition was more closely 
associated with lower extremity limitations than sarcopenia by Baumgartner’s definition. [6] 
Villareal et al. also showed that the percent body weight as fat-free mass was lower in obese 
elderly persons than non-obese non-frail subjects and non-obese frail subjects matched for age 
and sex. [7] In their study, despite a higher absolute amount of fat-free mass in the obese elderly, 
these subjects had lower muscle quality, poor functional performance, lower aerobic capacity, 
and reduced walking speed. Thus, these obese elderly adults had sarcopenia (low relative muscle 
mass and low muscle quality) despite having higher absolute amount of muscle mass. Sarcopenic 
obesity also predicts disability in instrumental activities of daily living (IADL) in the elderly. [8] 
The risk for incident disability in IADL was two to three times higher in sarcopenic obese 
subjects than non-sarcopenic obese subjects. [8] Unfortunately, the prevalence of sarcopenic 
obesity and its functional outcomes have never been studied in older adults with diabetes. This 
issue should be studied in the near future because the three greatest epidemiological trends of our 
times are the aging of the population and the epidemics of obesity and diabetes. [9]  
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 In any case, our study clearly revealed that older adults with diabetes lost excess amount of 
their muscle mass than non-diabetic adults in a longitudinal analysis. To our knowledge, this is 
the first study showing that diabetes is a risk factor for sarcopenia in older adults. It seems likely 
that diabetes may confer susceptibility to lose muscle mass independently of obesity and overall 
weight loss because an excess loss of muscle mass in our study is evident even after adjusting for 
baseline body composition and changes in body weight. In our study, older adults with either 
undiagnosed or diagnosed diabetes had higher rates of weight loss intention assessed at each 
examination year. (Table 19). However, adjustments for weight loss intention did not attenuate 
excess loss of muscle mass in older adults with diabetes. The assessment of weight loss intention 
is very subjective because it is usually based on a questionnaire like “At the present time, are you 
trying to lose weight?” (yes/no). We found that weight loss intention changed each year with 
moderate to poor agreements between examination years (Table 20).  In fact, actual weight 
changes up to 5 years were not different between participants intending and not intending to lose 
weight in our cohort (Table 21). [10] Moreover, in the Health ABC Study, the incidence of 
mobility limitation was not lower, but actually increased in older adults with intentional weight 
loss, especially in overweight (HR, 1.59; 95% CI, 1.12-2.25) and obese subjects (HR, 1.12; 95% 
CI, 0.70-1.79). [11] Not all, but some studies showed that intentional weight loss was associated 
with a reduced risk of all-cause mortality in middle aged adults. [12-14] However, in older adults, 
it is still unclear whether intentional weight loss is beneficial or not. This thesis is not designed to 
answer the above question. In the future, the issue of intentional weight loss should be explored 
in relation to muscle mass, strength and/or quality as well as physical function, disability, and 
mortality in older adults.  
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 Table 19. Rates (%) of having weight loss intention at each year by baseline diabetes status 
Examination year (n)  No diabetes Undiagnosed diabetes Diagnosed diabetes P value (X2 test) 
Year 1 (2,673) 24.7 33.6 31.7 0.001 
Year 2 (2,510)  30.8 41.7 35.0 0.003 
Year 3 (2,357) 27.2 34.7 28.8 0.083 
Year 4 (2,234) 29.2 30.6 31.1 0.758 
Year 5 (2,129) 27.5 28.5 28.6 0.893 
Year 6 (1,961) 26.1 29.2 30.1 0.306 
 
Table 20. Measures of agreement in weight loss intention assessed by questionnaire at each year  
Examination years Kappa statistics P-value 
Year 1 and 2 0.448 <0.01 
Year 1 and 3 0.414 <0.01 
Year 1 and 4 0.383 <0.01 
Year 1 and 5 0.374 <0.01 
Year 1 and 6 0.344 <0.01 
 
 
 
Table 21. Actual changes in body weight up to 5 years by weight loss intention  
Intervals (n)  Changes in weight (kg) 
Weight loss not intended         Weight loss intended 
P 
Years 1-2 (2,730) -0.31 ± 2.92 -0.36 ± 3.19 NS 
Years 1-3 (2,540)  -0.35 ± 3.75 -0.45 ± 3.94 NS 
Years 1-4 (2,401) -0.61 ± 4.17 -0.67 ± 4.38 NS 
Years 1-5 (2,294) -0.86 ± 4.66 -0.65 ± 4.88 NS 
Years 1-6 (2,099) -1.55 ± 4.91 -1.11 ± 5.10 NS 
NS: not significant 
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 5.2   MUSCLE STRENGTH AND QUALITY IN DIABETES 
 
          In cross-sectional analysis, older men with diabetes had lower muscle strength in the arm 
and knee than non-diabetic men. Muscle strength in older women with diabetes was not different 
from non-diabetic women. These results are completely against the general concept of the bigger 
the stronger. Our findings may imply that older adults with diabetes have double burden due to 
skeletal muscle weakness and a need to carry greater weight due to obesity. In fact, muscle 
quality (maximal strength per unit muscle mass) is consistently lower in both older men and 
women and in upper and lower extremities. Our findings strongly suggest that poor muscular 
function may act as a pathophysiological mechanism linking diabetes and physical limitations 
and disability. Unfortunately, this possibility has never been examined in the Health ABC cohort 
and other epidemiologic studies in older adults. [15-18] Future research should include 
measurements of skeletal muscle mass and strength to investigate potential association of muscle 
function and physical disability in older adults with diabetes. 
         Another novel finding of this study is a linear relationship between duration and severity of 
diabetes and poor muscle function. Muscle quality was the lowest in diabetic subjects with 
longer duration (> 6 years) and in those with poor glycemic control (A1c > 8%). It is consistent 
with previous findings in the Health ABC Study showing that diabetes with longer duration was 
associated with slow walking speed, poor standing balance, and lower summary physical 
performance score. [15] In addition, poor glycemic control among the diabetic population was 
associated with risk of subclinical functional limitation (OR 1.53 – 1.63) regardless of diabetes 
duration. [15] Poorer glycemic control in diabetes is associated with protein catabolism in 
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 skeletal muscle that may lead to loss of muscle mass and strength. Elevated inflammatory 
cytokines such as TNF-α and IL-6 may also be involved in this pathway. [19-20]  
Peripheral neuropathy in diabetes is associated with decreased muscle strength in adults 
with type 2 diabetes as well as type 1 diabetes. [21-23] Not only the presence of neuropathy but 
also the severity of neuropathy assessed as combination of neuropathy symptom score, 
neurological disability score, vibration perception threshold, and the average of the rank scores 
of the motor nerve conduction velocity, compound muscle action potential, sensory nerve 
conduction velocity, and sensory nerve action potential, linearly correlated with isokinetic 
muscle strength at ankle and knee. [21, 23] Electrophysiologic study suggested incomplete 
reinnervation of nerve fibers following axonal loss in subjects with diabetes. [22] In our study, 
we have no measurements of nerve function at baseline thus we are unable to examine this 
potential pathway. Further research in the Health ABC Study may be needed to investigate the 
potential role of nerve function on muscle strength as we have assessments of nerve function at 
year 4 with strength measurements. 
Whatever the mechanism, our longitudinal analysis clearly shows that older adults with 
diabetes lost about 50% greater amount of initial muscle strength than non-diabetic older adults 
in three years. Part of the rapid declines in muscle strength is attributable to greater loss of 
muscle mass. But, rapid declines in muscle strength is evident even after adjusting loss of muscle 
mass, suggesting there is a functional decline in muscle quality in older adults with diabetes. The 
result of longitudinal study confirms the cross-sectional association of diabetes and muscle 
weakness and highlights the importance of muscle quality.  
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 5.3   UNIFYING HYPOTHESIS 
 
         From the cross-sectional and longitudinal study of skeletal muscle phenotypes in older 
adults, we have found significant deteriorations in muscular function in those with diabetes. 
Furthermore, we were able to explore some potential mechanisms of this association although it 
is incomplete (Figure 6). 
Uncontrolled hyperglycemia 
Insulin deficiency 
Peripheral 
neuropathy 
Combined  
Obesity 
Catabolic milieu 
Inflammatory cytokines 
Loss of muscle mass 
Changes in muscle composition 
Poor muscular function 
Diabetes Mellitus 
Physical limitations 
Disability 
 
Axonal loss 
Incomplete reinnervation 
Increased burden  
due to high fat mass 
 
 
Figure 6. Unifying hypothesis explaining the association of diabetes and physical disability 
in older adults. 
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 5.4      LIMITATIONS OF STUDY 
 
       Although the Health ABC Study seem to be an ideal cohort to examine the impact of 
diabetes on skeletal muscle mass and strength in older adults, we have several limitations which 
restrains in depth exploration of the association and pathways. First, our study population is 
physically well-functioning older adults at baseline excluding about one third of all age-eligible 
subjects who had difficulty walking one quarter of a mile or climbing 10 steps without rest. 
These selection criteria excluded many elderly people with poor function. Our diabetic 
participants may be a healthier selective population than usual older adults with diabetes. 
Perhaps this selection of healthier population may underestimate true declines in muscle mass 
and strength and our result is conservative in this respect. Second, there are many drop outs for 
the follow-up assessments of muscle mass and strength because of high mortality and morbidity 
in the study population. Part of drop-out is inevitable considering advanced age (average 73.5 
years at baseline) of the population. Assessments of muscle mass require clinic visit of 
participants as we used DXA and CT. Furthermore, assessments of muscle strength require 
active involvement of participants especially for the knee strength tests. Many participants were 
excluded from knee strength test due to contraindications such as uncontrolled hypertension, 
recent stroke, brain aneurism, pain or history of joint replacement. However, as shown in the 
discussion of the second article, exclusion of participants for knee strength test biased the results 
to the null. Therefore, our findings are likely to be conservative. Third, we were unable to 
examine the influence of diabetic neuropathy as a potential pathway between diabetes and 
muscle function. But, the lack of nerve function assessment at baseline does not discount the 
significance of our findings because poor nerve function may be a mediator of association rather 
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 than confounding true association. Despite of these limitations, our study is novel as we clearly 
demonstrate the cross-sectional association of diabetes and poor muscle quality and it is 
confirmed by longitudinal analysis.  
   
5.5     FUTURE  RESEARCH 
 
 We have shown the impact of diabetes on skeletal muscle mass and strength in well 
defined cohort of older adults in the Health ABC Study. The next step will be “What is the 
clinical outcome of poor muscular function in older adults with diabetes?” Our findings suggest 
that poor muscular function in diabetes may have important role in the development of 
devastating outcomes like physical limitations and disability. Future study should identify the 
association of poor muscle function and clinical outcomes in older adults with diabetes. Secondly, 
biological mechanisms involved in the association of diabetes and poor muscle function need to 
be investigated more thoroughly. We have suggested some potential mechanisms such as 
uncontrolled hyperglycemia, inflammatory cytokines, and diabetic neuropathy. It seems very 
important to explore the association with nerve function because muscle function is under the 
direct control of nerve function and muscle and nerve are connected as a neuromuscular system 
rather than two separate systems. We hope this will be examined in the Health ABC Study by 
using year 4 data as a baseline. Thirdly, we have no clear answer why older adults with 
undiagnosed diabetes show greater declines in skeletal muscle mass. Many issues including 
intention to lose weight can be raised in this association. Modification of this association by 
treatment effects in known diabetes should also be explored.  
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 6. APPLICATION TO PUBLIC HEALTH 
 
The present study is the first epidemiologic study to assess skeletal muscle mass and 
strength in subjects with and without diabetes in apparently healthy, community dwelling older 
adults. Our study population includes white and black older men and women with type 2 diabetes 
in various clinical stages. The prevalence of diabetes is increasing especially in older adults and 
about one third of diabetes is remained undiagnosed. [1-3] If older adults with undiagnosed 
diabetes were left untreated they would be at high risk for weight loss, particularly loss of lean 
mass. It is important because accelerated loss of lean mass in older adults with diabetes might be 
related to muscle strength loss, functional limitations, and physical disability. [4-7]  
In our aging society, the diabetes epidemic continues to garner headlines, with the 
emergence of obesity epidemic. The prevalence of elderly diabetes is rising and the impact of 
elderly diabetes is likely to be dramatic in the next decade. [8] It is anticipated that elderly 
diabetes combined with obesity will give rise to huge public health problem. It is already evident 
that over 1.2 million (or approximately one-fourth) of older American diabetic adults either 
cannot walk one quarter of a mile, climb 10 stairs, or do housework. Over 2.5 million (or 
approximately one-half) have some difficulty doing these tasks. [4] Our results suggest that loss 
of muscle mass and strength may contribute to the functional disability in older adults with 
diabetes because adequate muscle mass and strength is essential for physical functioning.   
We are urgently in need to develop strategies to slow or prevent rapid declines in muscle 
mass and function in this high risk population of older adults with diabetes. Every potential ways 
such as strict glucose control and resistive training exercise programs should be examined 
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 thoroughly. [9] Now, it is time to develop preventive strategy to reduce anticipated devastating 
consequences in the high risk population of older adult with diabetes. 
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